Lars Egevad

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Lars Egevad är professor i tumörpatologi.

Artiklar

Article: EUROPEAN UROLOGY. 2025;:S0302-2838(25)04735-9
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial.
Vigneswaran HT; Palsdottir T; Micoli C; Tilki D; Lin D; Cooperberg M; Eggener S; Falagario UG; Möller A; Aly M; Akre O; Wiklund P; Egevad L; Grönberg H; Nordström T; Eklund M
Article: COMMUNICATIONS MEDICINE. 2025;5(1):425
Artificial intelligence-assisted prostate cancer diagnosis for reduced use of immunohistochemistry
Blilie A; Mulliqi N; Ji X; Szolnoky K; Boman SE; Titus M; Gonzalez GM; Asenjo J; Gambacorta M; Libretti P; Gudlaugsson E; Kjosavik SR; Egevad L; Janssen EAM; Eklund M; Kartasalo K
Article: PATHOLOGY. 2025;57(6):708-711
High proportion of clinically significant prostate adenocarcinomas in radical cystoprostatectomy specimens following complete prostate sampling
Delahunt B; Johannsen S; Egevad L; Yaxley JW; Le Fevre IK; Perry-Keene JL; Coughlin G; Samaratunga H
Article: MEDICAL IMAGE ANALYSIS. 2025;105:103663
Hierarchical Vision Transformers for prostate biopsy grading: Towards bridging the generalization gap
Grisi C; Kartasalo K; Eklund M; Egevad L; van der Laak J; Litjens G
Article: BJU INTERNATIONAL. 2025
Long-term oncological outcomes of bladder cancer: a population-based study with a 25-year follow-up
Dey L; Rautiola J; Akre O; Egevad L; Hosseini A; Mehrazin R; Patrakka J; Ranti D; Renstrom-Koskela L; Sfakianos J; Thiel T; Vincent PH; Yan J; Steineck G; Wiklund P
Article: BMJ OPEN. 2025;15(7):e097591
Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies: study protocol
Mulliqi N; Blilie A; Ji X; Szolnoky K; Olsson H; Titus M; Martinez Gonzalez G; Boman SE; Valkonen M; Gudlaugsson E; Kjosavik SR; Asenjo J; Gambacorta M; Libretti P; Braun M; Kordek R; Lowicki R; Hotakainen K; Vare P; Pedersen BG; Sorensen KD; Ulhoi BP; Rantalainen M; Ruusuvuori P; Delahunt B; Samaratunga H; Tsuzuki T; Janssen EAM; Egevad L; Kartasalo K; Eklund M
Article: BJU INTERNATIONAL. 2025;136(1):135-142
Positive surgical margin and oncological outcomes after robot-assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups
Hagman A; Lantz A; Grannas D; Carlsson S; Akre O; Olsson M; Egevad L; Hoijer J; Wiklund P
Article: JOURNAL OF CLINICAL PATHOLOGY. 2025;78(6):429-431
Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancers
Egevad L; Micoli C; Delahunt B; Samaratunga H; Garmo H; Stattin P; Eklund M
Article: MODERN PATHOLOGY. 2025;38(5):100715
Physical Color Calibration of Digital Pathology Scanners for Robust Artificial Intelligence-Assisted Cancer Diagnosis
Ji X; Salmon R; Mulliqi N; Khan U; Wang Y; Blilie A; Olsson H; Pedersen BG; Sorensen KD; Ulhoi BP; Kjosavik SR; Janssen EAM; Rantalainen M; Egevad L; Ruusuvuori P; Eklund M; Kartasalo K
Article: CELL DEATH & DISEASE. 2025;16(1):307
Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma
Akuma M; Kim M; Zhu C; Wiljer E; Gaudreau-Lapierre A; Patterson LD; Egevad L; Tanguay S; Trinkle-Mulcahy L; Stanford WL; Riazalhosseini Y; Russell RC
Article: PATHOLOGY. 2025;57(3):293-296
Gleason scores provide more accurate prognostic information than grade groups
Egevad L; Micoli C; Delahunt B; Samaratunga H; Garmo H; Stattin P; Eklund M
Article: EUROPEAN UROLOGY ONCOLOGY. 2025;8(1):80-86
Effectiveness and Cost-effectiveness of Artificial Intelligence-assisted Pathology for Prostate Cancer Diagnosis in Sweden: A Microsimulation Study
Du X; Hao S; Olsson H; Kartasalo K; Mulliqi N; Rai B; Menges D; Heintz E; Egevad L; Eklund M; Clements M
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2024;391(12):1083-1095
Results after Four Years of Screening for Prostate Cancer with PSA and MRI
Hugosson J; Godtman RA; Wallstrom J; Axcrona U; Bergh A; Egevad L; Geterud K; Khatami A; Socratous A; Spyratou V; Svensson L; Stranne J; Mansson M; Hellstrom M
Article: BJUI COMPASS. 2024;5(9):999-1006
Long-term oncological outcomes after multimodal treatment for locally advanced prostate cancer
Roldan FL; Falagario UG; Olsson M; Salas RS; Aly M; Egevad L; Lantz A; Gronberg H; Akre O; Hosseini A; Wiklund NP
Article: EUROPEAN UROLOGY ONCOLOGY. 2024;7(4):705-712
Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working Group
Falagario UG; Knipper S; Pellegrino F; Martini A; Akre O; Egevad L; Groenberg H; Moschovas MC; Bravi CA; Tran J; Heiniger Y; von Kempis A; Schaffar R; Carrieri G; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P
Article: EUROPEAN UROLOGY ONCOLOGY. 2024;7(4):888-896
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years Report from the EAU Robotic Urology Section Scientific Working Group '
Pellegrino F; Falagario UG; Knipper S; Martini A; Akre O; Egevad L; Aly M; Moschovas MC; Bravi CA; Tran J; Heiniger Y; von Kempis A; Schaffar R; Carrieri G; Briganti A; Montorsi F; Rochat C-H; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P
Article: VIRCHOWS ARCHIV. 2024;484(6):995-1003
Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study
Egevad L; Micoli C; Delahunt B; Samaratunga H; Orrason AW; Garmo H; Stattin P; Eklund M
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2024;59:76-83
Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer
Thomsen FF; Garmo H; Egevad L; Stattin P; Brasso K
Article: EUROPEAN UROLOGY ONCOLOGY. 2024;7(2):213-221
Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study
Egevad L; Micoli C; Samaratunga H; Delahunt B; Garmo H; Stattin P; Eklund M
Journal article: JOURNAL OF CLINICAL PATHOLOGY. 2024;77(3):164-168
Macroscopic examination of pathology specimens: a critical reappraisal
Varma M; Collins LC; Chetty R; Karamchandani DM; Talia K; Dormer J; Vyas M; Conn B; Guzman-Arocho YD; Jones AV; Pring M; Mccluggage WG
Journal article: PATHOLOGY. 2024;56(1):138-141
Myxoid pleomorphic liposarcoma of the orbit: intratumoural genetic similarities and heterogeneity
Tan GZL; Yong MH; Tiu LA; Dolendo M; Mok Y
Journal article: PATHOLOGY. 2024;56(1):138-141
Myxoid pleomorphic liposarcoma of the orbit: intratumoural genetic similarities and heterogeneity
Tan GZL; Yong MH; Tiu LA; Dolendo M; Mok Y
Article: PATHOLOGY. 2024;56(1):33-38
Gleason score 3+3[6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients
Samaratunga H; Egevad L; Yaxley J; Perry-Keene J; Le Fevre I; Kench J; Matsika A; Bostwick D; Iczkowski K; Delahunt B
Article: JOURNAL OF CLINICAL PATHOLOGY. 2023;77(1):22-26
Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading
Flach RN; Egevad L; Eklund M; van der Kwast TH; Delahunt B; Samaratunga H; Suelmann BBM; Willemse P-PM; Meijer RP; van Diest PJ
Article: UROLOGY. 2023;181:84-91
Surveillance for Nonmuscle Invasive Bladder Cancer: Identifying the Point of Diminishing Returns
Ranti D; Dey L; Bieber C; Grauer R; Rich J; Rosenzweig S; Koskela LR; Steineck G; Hosseini A; Egevad L; Patrakka J; Attalla K; Wiklund P; Sfakianos J; Waingankar N
Article: APMIS. 2023;131(10):528-535
Web-grading-a tool to test personal grading of renal and prostate cancer.
Kristiansen G; Schmid M; Egevad L; Samaratunga H; Varma M; Inam K; Thiesen H-J; Delahunt B; Dai Y
Article: CELLS. 2023;12(17):2158
Deciphering the Role of p60AmotL2 in Epithelial Extrusion and Cell Detachment
Cui W; Subramani A; Fonseca P; Zhang Y; Tong L; Zhang Y; Egevad L; Lundqvist A; Holmgren L
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2023;47(6):701-708
Clinicopathologic Significance of Anterior Prostate Cancer Comparison With Posterior Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging
Samaratunga H; Egevad L; Yaxley JWW; Johannsen S; Le Fevre IKK; Perry-Keene JLL; Gianduzzo T; Chabert C; Coughlin G; Parkinson R; Kua B; Yaxley W; Delahunt B
Article: HISTOPATHOLOGY. 2023;82(6):837-845
Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria
Egevad L; Delahunt B; Iczkowski KA; van der Kwast T; van Leenders GJLH; Leite KRM; Pan C-C; Samaratunga H; Tsuzuki T; Mulliqi N; Ji X; Olsson H; Valkonen M; Ruusuvuori P; Eklund M; Kartasalo K
Article: CLINICAL CANCER RESEARCH. 2023;29(7):1220-1231
Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
Vasudev NS; Scelo G; Glennon KI; Wilson M; Letourneau L; Eveleigh R; Nourbehesht N; Arseneault M; Paccard A; Egevad L; Viksna J; Celms E; Jackson SM; Abedi-Ardekani B; Warren AY; Selby PJ; Trainor S; Kimuli M; Cartledge J; Soomro N; Adeyoju A; Patel PM; Wozniak MB; Holcatova I; Brisuda A; Janout V; Chanudet E; Zaridze D; Moukeria A; Shangina O; Foretova L; Navratilova M; Mates D; Jinga V; Bogdanovic L; Kovacevic B; Cambon-Thomsen A; Bourque G; Brazma A; Tost J; Brennan P; Lathrop M; Riazalhosseini Y; Banks RE
Article: EBIOMEDICINE. 2023;88:104427
Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
Berbis MA; McClintock DS; Bychkov A; Van der Laak J; Pantanowitz L; Lennerz JK; Cheng JY; Delahunt B; Egevad L; Eloy C; Farris III AB; Fraggetta F; del Moral RG; Hartman DJ; Herrmann MD; Hollemans E; Iczkowski KA; Karsan A; Kriegsmann M; Salama ME; Sinard JH; Tuthill JM; Williams B; Casado-Sanchez C; Sanchez-Turrion V; Luna A; Aneiros-Fernandez J; Shen J
Article: NATURE COMMUNICATIONS. 2022;13(1):7761
Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction
Olsson H; Kartasalo K; Mulliqi N; Capuccini M; Ruusuvuori P; Samaratunga H; Delahunt B; Lindskog C; Janssen EAM; Blilie A; Egevad L; Spjuth O; Eklund M
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2022;387(23):2126-2137
Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only
Hugosson J; Mansson M; Wallstrom J; Axcrona U; Carlsson SV; Egevad L; Geterud K; Khatami A; Kohestani K; Pihl C-G; Socratous A; Stranne J; Godtman RA; Hellstrom M
Article: PATHOLOGY. 2022;54(7):842-847
LOT and HOT ... or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia
Samaratunga H; Egevad L; Thunders M; Iczskowski KA; van der Kwast T; Kristiansen G; Pan C-C; Leite KRM; Evans A; Clouston D; Kenwright DN; Bethwaite PB; Malone G; Wood S; Yaxley JW; Delahunt B
Article: BJU INTERNATIONAL. 2022;130(Suppl 3):40-45
Oncological and urinary outcomes following low-dose-rate brachytherapy with a median follow-up of 11.8 years
Yaxley WJ; Mackean J; Desai DJ; Tsang G; Dixon J; Samaratunga H; Delahunt B; Egevad L; Gardiner RA; Yaxley JW
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;44:69-75
Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
Andersson J; Palsdottir T; Lantz A; Aly M; Gronberg H; Egevad L; Eklund M; Nordstrom T
Article: PATHOLOGY. 2022;54(6):694-699
Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy
Yaxley W; Delahunt B; Yaxley J; Thundeer MC; Kenwright DN; Egevad L; Samaratunga H
Article: ISCIENCE. 2022;25(7):104663
Using deep learning to detect patients at risk for prostate cancer despite benign biopsies
Liu B; Wang Y; Weitz P; Lindberg J; Hartman J; Wang W; Egevad L; Gronberg H; Eklund M; Rantalainen M
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;41:1-7
External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort
Engel JC; Palsdottir T; Ankerst D; Remmers S; Mortezavi A; Chellappa V; Egevad L; Gronberg H; Eklund M; Nordstrom T
Article: VIRCHOWS ARCHIV. 2022;481(1):73-82
Detection of perineural invasion in prostate needle biopsies with deep neural networks
Kartasalo K; Strom P; Ruusuvuori P; Samaratunga H; Delahunt B; Tsuzuki T; Eklund M; Egevad L
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2022;49(9):3289-3294
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
Roberts MJ; Morton A; Papa N; Franklin A; Raveenthiran S; Yaxley WJ; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Emmett L; Yaxley JW
Article: BIOINFORMATICS. 2022;38(13):3462-3469
Transcriptome-wide prediction of prostate cancer gene expression from histopathology images using co-expression-based convolutional neural networks
Weitz P; Wang Y; Kartasalo K; Egevad L; Lindberg J; Gronberg H; Eklund M; Rantalainen M
Article: VACCINE. 2022;40(27):3797-3801
Travel vaccines are strongly associated to reduced mortality in prostate cancer patients-a real effect or residual confounding?
Moeller A; Schwamborn K; Spillmann A; Hoogstraate J; Szulkin R; Akre O; Egevad L; Clements M; Aly M
Article: PROSTATE. 2022;82(5):576-583
Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin
Lindh C; Samaratunga H; Delahunt B; Bergstrom R; Chellappa V; Yaxley J; Lindberg J; Egevad L
Article: JOURNAL OF UROLOGY. 2022;207(3):573-580
Findings in 1,123 Men with Preoperative ⁶⁸Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography and Multiparametric Magnetic Resonance Imaging Compared to Totally Embedded Radical Prostatectomy Histopathology: Implications for the Diagnosis and Management of Prostate Cancer
Raveenthiran S; Yaxley WJ; Franklin T; Coughlin G; Roberts M; Gianduzzo T; Kua B; Samaratunga H; Delahunt B; Egevad L; Wong D; McEwan L; Brown N; Parkinson R; Esler R; Yaxley JW
Article: PATHOLOGY. 2022;54(1):49-54
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial
Delahunt B; Steigler A; Atkinson C; Christie D; Duchesne G; Egevad L; Joseph D; Kenwright DN; Matthews J; Murray JD; Oldmeadow C; Samaratunga H; Spry NA; Thunders MC; Hondermarck H; Denham JW
Article: NATURE MEDICINE. 2022;28(1):154-163
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
Bulten W; Kartasalo K; Chen P-HC; Strom P; Pinckaers H; Nagpal K; Cai Y; Steiner DF; van Boven H; Vink R; Hulsbergen-van de Kaa C; van der Laak J; Amin MB; Evans AJ; van der Kwast T; Allan R; Humphrey PA; Gronberg H; Samaratunga H; Delahunt B; Tsuzuki T; Hakkinen T; Egevad L; Demkin M; Dane S; Tan F; Valkonen M; Corrado GS; Peng L; Mermel CH; Ruusuvuori P; Litjens G; Eklund M
Article: BIOINFORMATICS. 2021;37(21):3995-3997
OpenPhi: an interface to access Philips iSyntax whole slide images for computational pathology
Mulliqi N; Kartasalo K; Olsson H; Ji X; Egevad L; Eklund M; Ruusuvuori P
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2021;45(11):1527-1533
Intraductal Carcinoma of the Prostate Extreme Nuclear Size Is Not a Diagnostic Parameter
Samaratunga H; Delahunt B; Yaxley JW; Johannsen S; Egevad L
Article: EXPERIMENTAL AND MOLECULAR PATHOLOGY. 2021;122:104667
Nuclear and stromal expression of Manic fringe in renal cell carcinoma
Cheng WK; Kaur G; Sjoberg E; Frodin M; Egevad L; Harmenberg U; Li J-L; Oon CE
Article: JOURNAL OF SURGICAL ONCOLOGY. 2021;124(5):867-875
Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study
Thomsen FB; Garmo H; Brasso K; Egevad L; Stattin P
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2021;45(8):1118-1126
ISUP Consensus Definition of Cribriform Pattern Prostate Cancer
van der Kwast TH; van Leenders GJ; Berney DM; Delahunt B; Evans AJ; Iczkowski KA; McKenney JK; Ro JY; Samaratunga H; Srigley JR; Tsuzuki T; Varma M; Wheeler TM; Egevad L
Article: ANNALS OF DIAGNOSTIC PATHOLOGY. 2021;52:151733
Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts
Iczkowski KA; van Leenders GJLH; Tarima S; Wu R; Van der Kwast T; Berney DM; Evans AJ; Wheeler TM; Ro JY; Samaratunga H; Delahunt B; Srigley J; Varma M; Tsuzuki T; Egevad L
Article: HEAD AND NECK PATHOLOGY. 2021;15(2):628-637
Perithyroidal Salivary Gland Acinic Cell Carcinoma: Morphological and Molecular Attributes of a Unique Lesion
Juhlin CC; Asa SL; Jatta K; Rodsari HN; Shabo I; Haglund F; Delahunt B; Samaratunga H; Egevad L; Hoog A; Zedenius J
Article: VIRCHOWS ARCHIV. 2021;478(6):1109-1116
Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies
Egevad L; Delahunt B; Samaratunga H; Tsuzuki T; Olsson H; Strom P; Lindskog C; Hakkinen T; Kartasalo K; Eklund M; Ruusuvuori P
Article: VIRCHOWS ARCHIV. 2021;478(6):1099-1107
Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancer
Abedi-Ardekani B; Nasrollahzadeh D; Egevad L; Banks RE; Vasudev N; Holcatova I; Povysil C; Foretova L; Janout V; Mates D; Jinga V; Petrescu A; Milosavljevic S; Ognjanovic M; Ognjanovic S; Viksna J; Warren AY; Lathrop M; Riazalhosseini Y; Carreira C; Chanudet E; McKay J; Brennan P; Scelo G
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2021;24(2):398-405
Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications
Yaxley WJ; Nouhaud F-X; Raveenthiran S; Franklin A; Donato P; Coughlin G; Kua B; Gianduzzo T; Wong D; Parkinson R; Brown N; Samaratunga H; Delahunt B; Egevad L; Roberts M; Yaxley JW
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2021;113(5):632-640
Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)
Olsson H; Nordstrom T; Jaderling F; Egevad L; Vigneswaran HT; Annerstedt M; Gronberg H; Eklund M; Lantz A
Article: PATHOLOGE. 2021;42(3):310-318
Molecular pathology of urogenital tumors Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference
Hommerding O; Allory Y; Argani P; Bismar TA; Bubendorf L; Canete-Portillo S; Chaux A; Chen Y-B; Cheng L; Cubilla AL; Egevad L; Gill AJ; Grignon DJ; Hartmann A; Hes O; Idrees MT; Kao C-S; Knowles MA; Looijenge LHJ; Lota TLN; Pritchard CC; Rubin MA; Fins SAT; Van der Kwast TH; Velazquez EF; Warrick JI; Williamson SR; Kristiansen G
Article: APMIS. 2021;129(4):204-212
Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer
Stinnesbeck M; Kristiansen A; Ellinger J; Hauser S; Egevad L; Tolkach Y; Kristiansen G
Article: MODERN PATHOLOGY. 2021;34(3):660-671
Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists
Bulten W; Balkenhol M; Belinga J-JA; Brilhante A; Cakir A; Egevad L; Eklund M; Farre X; Geronatsiou K; Molinie V; Pereira G; Roy P; Saile G; Salles P; Schaafsma E; Tschui J; Vos A-M; van Boven H; Vink R; van der Laak J; Hulsbergen-van der Kaa C; Litjens G
Article: PLOS ONE. 2021;16(2):e0246674
The cost-effectiveness of prostate cancer screening using the Stockholm3 test
Karlsson AA; Hao S; Jauhiainen A; Elfstrom KM; Egevad L; Nordstrom T; Heintz E; Clements MS
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2021;24:11-16
Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms
Nordstrom T; Engel JC; Bergman M; Egevad L; Aly M; Eklund M; Palsdottir T; Gronberg H
Article: PATHOLOGY. 2021;53(2):199-204
Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy
Franklin A; Delahunt B; Egevad L; Yaxley J; Johannsen S; Gianduzzo T; Ganter J; Pecoraro C; Thunders M; Samaratunga H
Article: PATHOLOGY. 2021;53(1):120-128
Staging of renal cell carcinoma: current progress and potential advances
Delahunt B; Eble JN; Samaratunga H; Thunders M; Yaxley JW; Egevad L
Article: BJU INTERNATIONAL. 2021;127(1):71-79
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and⁶⁸Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
Article: PATHOLOGY. 2021;53(1):44-55
Tumour-like lesions of the urinary bladder
Samaratunga H; Delahunt B; Yaxley J; Egevad L
Article: PATHOLOGY. 2021;53(1):26-35
Benign mimics of prostate cancer
Egevad L; Delahunt B; Furusato B; Tsuzuki T; Yaxley J; Samaratunga H
Article: VIRCHOWS ARCHIV. 2020;477(6):777-786
Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading
Egevad L; Swanberg D; Delahunt B; Strom P; Kartasalo K; Olsson H; Berney DM; Bostwick DG; Evans AJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; Leite KRM; McKenney JK; Oxley J; Pan C-C; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; van der Kwast T; Varma M; Zhou M; Clements M; Eklund M
Article: JOURNAL OF CLINICAL PATHOLOGY. 2020;73(10):630-635
Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy
Strom P; Nordstrom T; Delahunt B; Samaratunga H; Gronberg H; Egevad L; Eklund M
Article: PATHOLOGY. 2020;52(5):507-514
Granular necrosis: a distinctive form of cell death in malignant tumours
Samaratunga H; Delahunt B; Srigley JR; Berney DM; Cheng L; Evans A; Furusat B; Leite KRM; MacLennan GT; Martignoni G; Moch H; Pan C-C; Paner G; Ro J; Thunders M; Tsuzuki T; Wheeler T; Kwast TVD; Varma M; Williamson SR; Yaxley JW; Egevad L
Article: HISTOPATHOLOGY. 2020;77(2):284-292
Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial
Delahunt B; Murray JD; Steigler A; Atkinson C; Christie D; Duchesne G; Egevad L; Joseph D; Matthews J; Oldmeadow C; Samaratunga H; Spry NA; Srigley JR; Hondermarck H; Denham JW
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):859-861
The International Society of Urological Pathology Consultation on Molecular Pathology of Urogenital Cancer
van der Kwast TH; Egevad L; Kristiansen G; Grignon DJ
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):e47-e65
Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers III: Molecular Pathology of Kidney Cancer
Williamson SR; Gill AJ; Argani P; Chen Y-B; Egevad L; Kristiansen G; Grignon DJ; Hes O
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):e80-e86
Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers V Recommendations on the Use of Immunohistochemical and Molecular Biomarkers in Penile Cancer
Canete-Portillo S; Velazquez EF; Kristiansen G; Egevad L; Grignon D; Chaux A; Cubilla AL
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):e66-e79
Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors
Looijenga LHJ; Van der Kwast TH; Grignon D; Egevad L; Kristiansen G; Kao C-S; Idrees MT
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):e30-e46
Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer Progress and Challenges
Warrick JI; Knowles MA; Yves A; van der Kwast T; Grignon DJ; Kristiansen G; Egevad L; Hartmann A; Cheng L
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020;44(7):e15-e29
Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer
Lotan TL; Tomlins SA; Bismar TA; Van der Kwast TH; Grignon D; Egevad L; Kristiansen G; Pritchard CC; Rubin MA; Bubendorf L
Article: CELL DEATH DISCOVERY. 2020;6(1):42
Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells
Cheteh EH; Sarne V; Ceder S; Bianchi J; Augsten M; Rundqvist H; Egevad L; Ostman A; Wiman KG
Article: JOURNAL OF PATHOLOGY. 2020;250(4):387-396
Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma
Morin E; Lindskog C; Johansson M; Egevad L; Sandstrom P; Harmenberg U; Claesson-Welsh L; Sjoberg E
Article: LANCET ONCOLOGY. 2020;21(2):222-232
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
Strom P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan C-C; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wahlby C; Gronberg H; Rantalainen M; Egevad L; Eklund M
Article: BJU INTERNATIONAL. 2020;125(2):270-275
The natural history of untreated muscle-invasive bladder cancer
Martini A; Sfakianos JP; Renstrom-Koskela L; Mortezavi A; Falagario UG; Egevad L; Hosseini A; Mehrazin R; Galsky MD; Steineck G; Wiklund NP
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(1):1-6
Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml
Engel JC; Palsdottir T; Aly M; Egevad L; Gronberg H; Eklund M; Nordstrom T
Article: MODERN PATHOLOGY. 2019;32(9):1310-1319
Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome
Hammarsten P; Josefsson A; Thysell E; Lundholm M; Hagglof C; Iglesias-Gato D; Flores-Morales A; Stattin P; Egevad L; Granfors T; Wikstrom P; Bergh A
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2019;43(9):1249-1252
Is the UICC/AJCC pT2 Staging Category for Clear Cell Renal Cell Carcinoma Meaningful?
Delahunt B; Dagher J; Egevad L; Yaxley J; Varma M; Samaratunga H
Article: BMJ OPEN. 2019;9(8):e027860
PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design
Ahlberg MS; Adami H-O; Beckmann K; Bertilsson H; Bratt O; Cahill D; Egevad L; Garmo H; Holmberg L; Johansson E; Rannikko A; Van Hemelrijck M; Jaderling F; Wassberg C; Aberg UWN; Bill-Axelson A
Article: MOLECULAR ONCOLOGY. 2019;13(8):1763-1777
Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor
Thysell E; Vidman L; Ylitalo EB; Jernberg E; Crnalic S; Iglesias-Gato D; Flores-Morales A; Stattin P; Egevad L; Widmark A; Ryden P; Bergh A; Wikstrom P
Article: APMIS. 2019;127(8):554-560
PD-L1 expression and deficient mismatch repair in ductal adenocarcinoma of the prostate
Lindh C; Kis L; Delahunt B; Samaratunga H; Yaxley J; Wiklund NP; Clements M; Egevad L
Article: PLOS ONE. 2019;14(6):e0218280
Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study
Palsdottir T; Nordstrom T; Aly M; Lindberg J; Clements M; Egevad L; Gronberg H; Eklund M
Article: PROSTATE. 2019;79(8):920-928
Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer
Kristiansen A; Bergstrom R; Delahunt B; Samaratunga H; Gudjonsdottir J; Gronberg H; Egevad L; Lindberg J
Article: PATHOLOGY. 2019;51(4):349-352
Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Varma M; Samaratunga H
Article: VIRCHOWS ARCHIV. 2019;474(5):577-584
The International Society of Urological Pathology Education weba web-based system for training and testing of pathologists
Egevad L; Delahunt B; Samaratunga H; Leite KRM; Efremovs G; Furusato B; Han M; Jufe L; Tsuzuki T; Wang Z; Hornblad J; Clements M
Article: HISTOPATHOLOGY. 2019;74(6):844-852
Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web-based survey by the European Network of Uropathology
Prendeville S; Berney DM; Bubendorf L; Comperat E; Egevad L; Hes O; Kristiansen G; Oxley J; van Leenders GJLH; Varma M; van der Kwast T
Article: JOURNAL OF UROLOGY. 2019;201(4):815-820
Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with ⁶⁸Ga-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node Pathology
Yaxley JW; Raveenthiran S; Nouhaud F-X; Samartunga H; Yaxley AJ; Coughlin G; Delahunt B; Egevad L; McEwan L; Wong D
Article: PROSTATE. 2019;79(5):435-445
Prostate cancer induces C/EBP expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome
Adamo H; Hammarsten P; Hagglof C; Scherdin TD; Egevad L; Stattin P; Bergstrom SH; Bergh A
Article: PATHOLOGY. 2019;51(1):11-20
Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Egevad L; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Kench JG
Article: HISTOPATHOLOGY. 2019;74(2):284-290
Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H
Article: GENOME MEDICINE. 2018;10(1):85
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
Mayrhofer M; De Laere B; Whitington T; Van Oyen P; Ghysel C; Ampe J; Ost P; Demey W; Hoekx L; Schrijvers D; Brouwers B; Lybaert W; Everaert E; De Maeseneer D; Strijbos M; Bols A; Fransis K; Oeyen S; van Dam P-J; Van den Eynden G; Rutten A; Aly M; Nordstrom T; Van Laere S; Rantalainen M; Rajan P; Egevad L; Ullen A; Yachnin J; Dirix L; Gronberg H; Lindberg J
Article: BRITISH JOURNAL OF CANCER. 2018;119(7):840-846
A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis
Sjoberg E; Frodin M; Lovrot J; Mezheyeuski A; Johansson M; Harmenberg U; Egevad L; Sandstrom P; Ostman A
Article: EUROPEAN UROLOGY FOCUS. 2018;4(5):707-710
The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing
Eklund M; Nordstrom T; Aly M; Adolfsson J; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Presti JC; StLezin M; Clements M; Egevad L; Gronberg H
Article: EUROPEAN UROLOGY. 2018;74(2):204-210
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
Strom P; Nordstrom T; Aly M; Egevad L; Gronberg H; Eklund M
Article: HISTOPATHOLOGY. 2018;73(1):8-18
Utility of Pathology Imagebase for standardisation of prostate cancer grading
Egevad L; Delahunt B; Berney DM; Bostwick DG; Cheville J; Comperat E; Evans AJ; Fine SW; Grignon DJ; Humphrey PA; Hornblad J; Iczkowski KA; Kench JG; Kristiansen G; Leite KRM; Magi-Galluzzi C; McKenney JK; Oxley J; Pan C-C; Samaratunga H; Srigley JR; Takahashi H; True LD; Tsuzuki T; van der Kwast T; Varma M; Zhou M; Clements M
Article: PATHOLOGY. 2018;50(4):382-388
Macroscopic features of prostate cancer
Lindh C; Delahunt B; Egevad L
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2018;42(6):e33-e43
Intraoperative Consultation and Macroscopic Handling The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations
Verrill C; Perry-Keene J; Srigley JR; Zhou M; Humphrey PA; Lopez-Beltran A; Egevad L; Ulbright TM; Tickoo SK; Epstein JI; Comperat E; Berney DM
Article: VIRCHOWS ARCHIV. 2018;472(4):599-604
Handling and reporting of transperineal template prostate biopsy in Europe: a web-based survey by the European Network of Uropathology (ENUP)
Kammerer-Jacquet S-F; Comperat E; Egevad L; Hes O; Oxley J; Varma M; Kristiansen G; Berney DM
Article: EUROPEAN UROLOGY FOCUS. 2018;4(3):385-387
Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model
Nordstrom T; Gronberg H; Adolfsson J; Egevad L; Aly M; Eklund M
Article: EUROPEAN UROLOGY FOCUS. 2018;4(3):351-359
Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up
Rajan P; Hagman A; Sooriakumaran P; Nyberg T; Wallerstedt A; Adding C; Akre O; Carlsson S; Hosseini A; Olsson M; Egevad L; Wiklund F; Steineck G; Wiklund NP
Article: HISTOPATHOLOGY. 2018;72(3):481-489
A novel technique for biobanking of large sections of radical prostatectomy specimens
Lindh C; Delahunt B; Samaratunga H; Yaxley J; Gudjonsdottir J; Clements M; Lindberg J; Egevad L
Article: WORLD JOURNAL OF UROLOGY. 2018;36(1):15-20
Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques
Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
Article: HISTOPATHOLOGY. 2017;71(6):918-925
Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
Article: PATHOLOGY. 2017;49(7):715-720
Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study
Kristiansen A; Drevin L; Delahunt B; Samaratunga H; Robinson D; Lissbrant IF; Stattin P; Egevad L
Article: HISTOPATHOLOGY. 2017;71(5):677-685
Pathology Imagebase-a reference image database for standardization of pathology
Egevad L; Cheville J; Evans AJ; Hornblad J; Kench JG; Kristiansen G; Leite KRM; Magi-Galluzzi C; Pan C-C; Samaratunga H; Srigley JR; True L; Zhou M; Clements M; Delahunt B
Article: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(31):3566-3574
Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational Study
Rajan P; Sooriakumaran P; Nyberg T; Akre O; Carlsson S; Egevad L; Steineck G; Wiklund NP
Article: HUMAN PATHOLOGY. 2017;69:1-7
Genetic profile of ductal adenocarcinoma of the prostate
Seipel AH; Whitington T; Delahunt B; Samaratunga H; Mayrhofer M; Wiklund P; Gronberg H; Lindberg J; Egevad L
Article: HISTOPATHOLOGY. 2017;71(4):641-647
Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases
Samaratunga H; Delahunt B; Srigley JR; Yaxley J; Johannsen S; Coughlin G; Gianduzzo T; Kua B; Patterson I; Nacey JN; Egevad L
Article: ONCOTARGET. 2017;8(36):60257-60269
Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue
Radestad E; Egevad L; Jorns C; Mattsson J; Sundberg B; Nava S; Ericzon B-G; Henningsohn L; Levitsky V; Uhlin M
Article: EUROPEAN UROLOGY. 2017;72(1):22-31
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors
Lalonde E; Alkallas R; Chua MLK; Fraser M; Haider S; Meng A; Zheng J; Yao CQ; Picard V; Orain M; Hovington H; Murgic J; Berlin A; Lacombe L; Bergeron A; Fradet Y; Tetu B; Lindberg J; Egevad L; Gronberg H; Ross-Adams H; Lamb AD; Halim S; Dunning MJ; Neal DE; Pintilie M; van der Kwast T; Bristow RG; Boutros PC
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2017;41(6):e22-e32
Reporting and Staging of Testicular Germ Cell Tumors The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations
Verrill C; Yilmaz A; Srigley JR; Amin MB; Comperat E; Egevad L; Ulbright TM; Tickoo SK; Berney DM; Epstein JI; Delahunt B; Magi-Galluzzi C; Algaba F; Oliva E; Montironi R; Young RH; Idrees MT; Williamson SR; Zhou M; Humphrey PA; Lopez-Beltran A; Perry-Keene J
Article: CELL DEATH & DISEASE. 2017;8(6):e2848
Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death
Cheteh EH; Augsten M; Rundqvist H; Bianchi J; Sarne V; Egevad L; Bykov VJN; Ostman A; Wiman KG
Article: EUROPEAN UROLOGY. 2017;71(5):776-787
Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response
Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikstrom P
Article: SCIENTIFIC REPORTS. 2017;7:44876
Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma
Arseneault M; Monlong J; Vasudev NS; Laskar RS; Safisamghabadi M; Harnden P; Egevad L; Nourbehesht N; Panichnantakul P; Holcatova I; Brisuda A; Janout V; Kollarova H; Foretova L; Navratilova M; Mates D; Jinga V; Zaridze D; Mukeria A; Jandaghi P; Brennan P; Brazma A; Tost J; Scelo G; Banks RE; Lathrop M; Bourque G; Riazalhosseini Y
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2017;41(2):253-262
Rhabdoid and Undifferentiated Phenotype in Renal Cell Carcinoma Analysis of 32 Cases Indicating a Distinctive Common Pathway of Dedifferentiation Frequently Associated With SWI/SNF Complex Deficiency
Agaimy A; Cheng L; Egevad L; Feyerabend B; Hes O; Keck B; Pizzolitto S; Sioletic S; Wullich B; Hartmann A
Article: BRITISH JOURNAL OF CANCER. 2017;116(2):195-201
Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
Frodin M; Mezheyeuski A; Corvigno S; Harmenberg U; Sandstrom P; Egevad L; Johansson M; Ostman A
Article: BJU INTERNATIONAL. 2017;119(1):50-56
Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012
Danneman D; Drevin L; Delahunt B; Samaratunga H; Robinson D; Bratt O; Loeb S; Stattin P; Egevad L
Article: SCIENTIFIC REPORTS. 2016;6:36149
Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer
Mezheyeuski A; Hrynchyk I; Karlberg M; Portyanko A; Egevad L; Ragnhammar P; Edler D; Glimelius B; Ostman A
Article: JOURNAL OF SURGICAL ONCOLOGY. 2016;114(6):664-670
Prognostic Implications of 2005 Gleason Grade Modification. Population-Based Study of Biochemical Recurrence Following Radical Prostatectomy
Thomsen FB; Folkvaljon Y; Brasso K; Loeb S; Robinson D; Egevad L; Stattin P
Article: PLOS ONE. 2016;11(10):e0164016
High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting
Hammarsten P; Scherdin TD; Hagglof C; Andersson P; Wikstrom P; Stattin P; Egevad L; Granfors T; Bergh A
Article: JOURNAL OF CLINICAL PATHOLOGY. 2016;69(10):852-857
Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists
Varma M; Egevad L; Algaba F; Berney D; Bubendorf L; Camparo P; Comperat E; Erbersdobler A; Griffiths D; Grobholz R; Haitel A; Hulsbergen-van de Kaa C; Langner C; Loftus B; Lopez-Beltran A; Mayer N; Nesi G; Oliveira P; Oxley J; Rioux-Leclercq N; Seitz G; Shanks J; Kristiansen G
Article: HISTOPATHOLOGY. 2016;69(3):441-449
Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists
Kweldam CF; Nieboer D; Algaba F; Amin MB; Berney DM; Billis A; Bostwick DG; Bubendorf L; Cheng L; Comperat E; Delahunt B; Egevad L; Evans AJ; Hansel DE; Humphrey PA; Kristiansen G; van der Kwast TH; Magi-Galluzzi C; Montironi R; Netto GJ; Samaratunga H; Srigley JR; Tan PH; Varma M; Zhou M; van Leenders GJLH
Article: MOLECULAR ONCOLOGY. 2016;10(6):825-837
Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels
Haldrup C; Lynnerup A-S; Storebjerg TM; Vang S; Wild P; Visakorpi T; Arsov C; Schulz WA; Lindberg J; Groenberg H; Egevad L; Borre M; Orntoft TF; Hoyer S; Sorensen KD
Article: EUROPEAN UROLOGY. 2016;69(6):1135-1141
Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort
Loeb S; Folkvaljon Y; Robinson D; Lissbrant IF; Egevad L; Stattin P
Article: EUROPEAN UROLOGY. 2016;69(5):942-952
The Proteome of Primary Prostate Cancer
Iglesias-Gato D; Wikstrom P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hagglof C; Cox J; Andren O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
Article: NATURE GENETICS. 2016;48(4):387-397
Gene regulatory mechanisms underpinning prostate cancer susceptibility
Whitington T; Gao P; Song W; Ross-Adams H; Lamb AD; Yang Y; Svezia I; Klevebring D; Mills IG; Karlsson R; Halim S; Dunning MJ; Egevad L; Warren AY; Neal DE; Gronberg H; Lindberg J; Wei G-H; Wiklund F
Article: BJU INTERNATIONAL. 2016;117:7-8
Prostate cancer grading: recent developments and future directions
Delahunt B; Egevad L; Grignon DJ; Srigley JR; Samaratunga H
Article: APMIS. 2016;124(4):263-270
Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study
Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
Article: HISTOPATHOLOGY. 2016;68(4):533-540
Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation
Samaratunga H; Delahunt B; Egevad L; Adamson M; Hussey D; Malone G; Hoyle K; Nathan T; Kerle D; Ferguson P; Nacey JN
Article: EUROPEAN UROLOGY. 2016;69(3):428-435
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
Epstein JI; Zelefsky MJ; Sjoberg DD; Nelson JB; Egevad L; Magi-Galluzzi C; Vickers AJ; Parwani AV; Reuter VE; Fine SW; Eastham JA; Wiklund P; Han M; Reddy CA; Ciezki JP; Nyberg T; Klein EA
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2016;40(2):244-252
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA
Article: PATHOLOGE. 2016;37(1):17-26
The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma
Kristiansen G; Egevad L; Amin M; Delahunt B; Srigley JR; Humphrey PA; Epstein JI
Article: LANCET ONCOLOGY. 2015;16(16):1667-1676
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Article: ONCOTARGET. 2015;6(35):37066-37082
Sorafenib-induced defective autophagy promotes cell death by necroptosis
Kharaziha P; Chioureas D; Baltatzis G; Fonseca P; Rodriguez P; Gogvadze V; Lennartsson L; Bjorklund A-C; Zhivotovsky B; Grander D; Egevad L; Nilsson S; Panaretakis T
Article: SCIENTIFIC REPORTS. 2015;5:15651
Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions
Lundholm M; Hagglof C; Wikberg ML; Stattin P; Egevad L; Bergh A; Wikstrom P; Palmqvist R; Edin S
Article: PLOS ONE. 2015;10(10):e0140985
High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting
Nilsson M; Hagglof C; Hammarsten P; Thysell E; Stattin P; Egevad L; Granfors T; Jernberg E; Wikstrom P; Bergstrom SH; Bergh A
Article: PATHOLOGY. 2015;47(6):515-519
The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer
Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J
Article: PATHOLOGY. 2015;47(6):520-525
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data
Delahunt B; Egevad L; Srigley JR; Steigler A; Murray JD; Atkinson C; Matthews J; Duchesne G; Spry NA; Christie D; Joseph D; Attia J; Denham JW
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2015;39(10):1331-1339
Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations
Zhou M; Li J; Cheng L; Egevad L; Deng F-M; Kunju LP; Magi-Galluzzi C; Melamed J; Mehra R; Mendrinos S; Osunkoya AO; Paner G; Shen SS; Tsuzuki T; Trpkov K; Tian W; Yang X; Shah RB
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2015;39(9):1242-1249
Diagnosis of Gleason Pattern 5 Prostate Adenocarcinoma on Core Needle Biopsy An Interobserver Reproducibility Study Among Urologic Pathologists
Shah RB; Li J; Cheng L; Egevad L; Deng F-M; Fine SW; Kunju LP; Melamed J; Mehra R; Osunkoya AO; Paner GP; Shen SS; Tsuzuki T; Trpkov K; Tian W; Yang XJ; Zhou M
Article: HISTOPATHOLOGY. 2015;67(3):313-324
Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists
Berney DM; Algaba F; Amin M; Delahunt B; Comperat E; Epstein JI; Humphrey P; Idrees M; Lopez-Beltran A; Magi-Galluzzi C; Mikuz G; Montironi R; Oliva E; Srigley J; Reuter VE; Trpkov K; Ulbright TM; Varma M; Verrill C; Young RH; Zhou M; Egevad L
Article: EBIOMEDICINE. 2015;2(9):1133-1144
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
Ross-Adams H; Lamb AD; Dunning MJ; Halim S; Lindberg J; Massie CM; Egevad LA; Russell R; Ramos-Montoya A; Vowler SL; Sharma NL; Kay J; Whitaker H; Clark J; Hurst R; Gnanapragasam VJ; Shah NC; Warren AY; Cooper CS; Lynch AG; Stark R; Mills IG; Groenberg H; Neal DE
Article: BJU INTERNATIONAL. 2015;116(2):213-219
Upper limit of cancer extent on biopsy defining very low-risk prostate cancer
Bratt O; Folkvaljon Y; Loeb S; Klotz L; Egevad L; Stattin P
Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2015;34(1):62
Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth
Alexeyenko A; Alkasalias T; Pavlova T; Szekely L; Kashuba V; Rundqvist H; Wiklund P; Egevad L; Csermely P; Korcsmaros T; Guven H; Klein G
Article: EUROPEAN UROLOGY. 2015;67(5):819-822
Tracking the Origin of Metastatic Prostate Cancer
Lindberg J; Kristiansen A; Wiklund P; Gronberg H; Egevad L
Article: BJU INTERNATIONAL. 2015;115(2):248-255
Gleason inflation 1998-2011: a registry study of 97 168 men
Danneman D; Drevin L; Robinson D; Stattin P; Egevad L
Article: MOLECULAR CANCER. 2015;14(1):8
OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo
Iglesias-Gato D; Chuan Y-C; Jiang N; Svensson C; Bao J; Paul I; Egevad L; Kessler BM; Wikstorm P; Niu Y; Flores-Morales A
Article: BJU INTERNATIONAL. 2015;115(1):106-113
The impact of length and location of positive margins in predicting biochemical recurrence after robot-assisted radical prostatectomy with a minimum follow-up of 5 years
Sooriakumaran P; Ploumidis A; Nyberg T; Olsson M; Akre O; Haendler L; Egevad L; Nilsson A; Carlsson S; Jonsson M; Adding C; Hosseini A; Steineck G; Wiklund P
Article: ANNALES DE PATHOLOGIE. 2014;34(6):448-461
Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations
Rioux-Leclercq N; Ferran A; Mahul A; Argani P; Billis A; Bonsib S; Cheng L; Cheville J; Eble J; Egevad L; Epstein J; Grignon D; Hes O; Humphrey P; Magi-Galluzzi C; Martignoni G; McKenney J; Merino M; Moch H; Montironi R; Netto G; Reuter V; Samaratunga H; Shen S; Srigley J; Tamboli P; Tan PH; Tickoo S; Trpkov K; Zhou M; Delahunt B; Comperat E
Article: ANNALS OF DIAGNOSTIC PATHOLOGY. 2014;18(6):333-342
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists
Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane HR; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
Article: VIRCHOWS ARCHIV. 2014;465(6):623-628
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist
Montironi R; Hammond EH; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin MA; Nacey J; Klotz L; Sandler H; Zietman AL; Holden S; Humphrey PA; Evans AJ; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan A; True L; Knudsen B; Epstein JI; Amin MB
Article: ONCOGENE. 2014;33(45):5274-5287
N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype
Whitaker HC; Shiong LL; Kay JD; Groenberg H; Warren AY; Seipel A; Wiklund F; Thomas B; Wiklund P; Miller JL; Menon S; Ramos-Montoya A; Vowler SL; Massie C; Egevad L; Neal DE
Article: VIRCHOWS ARCHIV. 2014;465(5):559-565
Immunohistochemical profile of ductal adenocarcinoma of the prostate
Seipel AH; Samaratunga H; Delahunt B; Wiklund F; Wiklund P; Lindberg J; Gronberg H; Egevad L
Article: NATURE COMMUNICATIONS. 2014;5:5135
Variation in genomic landscape of clear cell renal cell carcinoma across Europe
Scelo G; Riazalhosseini Y; Greger L; Letourneau L; Gonzalez-Porta M; Wozniak MB; Bourgey M; Harnden P; Egevad L; Jackson SM; Karimzadeh M; Arseneault M; Lepage P; How-Kit A; Daunay A; Renault V; Blanche H; Tubacher E; Sehmoun J; Viksna J; Celms E; Opmanis M; Zarins A; Vasudev NS; Seywright M; Abedi-Ardekani B; Carreira C; Selby PJ; Cartledge JJ; Byrnes G; Zavadil J; Su J; Holcatova I; Brisuda A; Zaridze D; Moukeria A; Foretova L; Navratilova M; Mates D; Jinga V; Artemov A; Nedoluzhko A; Mazur A; Rastorguev S; Boulygina E; Heath S; Gut M; Bihoreau M-T; Lechner D; Foglio M; Gut IG; Skryabin K; Prokhortchouk E; Cambon-Thomsen A; Rung J; Bourque G; Brennan P; Tost J; Banks RE; Brazma A; Lathrop GM
Article: PROSTATE. 2014;74(14):1391-1399
Novel Method to Characterize Immune Cells From Human Prostate Tissue
Norstrom MM; Radestad E; Stikvoort A; Egevad L; Bergqvist M; Henningsohn L; Mattsson J; Levitsky V; Uhlin M
Article: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2014;138(10):1387-1405
The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer Consensus Statement With Recommendations Supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation
Amin MB; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin M; Nacey J; Carter HB; Klotz L; Sandler H; Zietman AL; Holden S; Montironi R; Humphrey PA; Evans AJ; Epstein JI; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan AM; True L; Knudsen B; Hammond MEH
Article: PLOS ONE. 2014;9(9):e105063
ErbB2 Receptor Immunoreactivity in Prostate Cancer: Relationship to the Androgen Receptor, Disease Severity at Diagnosis and Disease Outcome
Hammarsten P; Winther J; Rudolfsson SH; Haggstrom J; Karalija A; Egevad L; Granfors T; Fowler CJ
Article: HUMAN PATHOLOGY. 2014;45(9):1805-1812
Seminal vesicle intraepithelial involvement by prostate cancer: putative mechanism and clinicopathological significance
Miyai K; Kristiansen A; Egevad L; Pina-Oviedo S; Divatia MK; Shen SS; Miles BJ; Ayala AG; Park YW; Ro JY
Article: PLOS ONE. 2014;9(8):e104417
Evaluation of Exome Sequencing to Estimate Tumor Burden in Plasma
Klevebring D; Neiman M; Sundling S; Eriksson L; Ramqvist ED; Celebioglu F; Czene K; Hall P; Egevad L; Groenberg H; Lindberg J
Article: HISTOPATHOLOGY. 2014;65(2):216-227
Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists
Seipel AH; Delahunt B; Samaratunga H; Amin M; Barton J; Berney DM; Billis A; Cheng L; Comperat E; Evans A; Fine SW; Grignon D; Humphrey PA; Magi-Galluzzi C; Montironi R; Sesterhenn I; Srigley JR; Trpkov K; van der Kwast T; Varma M; Zhou M; Ahmad A; Moss S; Egevad L
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2014;38(8):e6-e19
Best Practices Recommendations in the Application of Immunohistochemistry in the Prostate Report From the International Society of Urologic Pathology Consensus Conference
Epstein JI; Egevad L; Humphrey PA; Montironi R; Amin MB; Ulbright TM; Grignon D; Trpkov K; Lopez-Beltran A; Zhou M; Argani P; Delahunt B; Berney DM; Srigley JR; Tickoo SK; Reuter VE
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2014;38(8):e20-e34
Best Practices Recommendations in the Application of Immunohistochemistry in the Bladder Lesions Report From the International Society of Urologic Pathology Consensus Conference
Amin MB; Trpkov K; Lopez-Beltran A; Grignon D; Epstein JI; Ulbright TM; Humphrey PA; Egevad L; Montironi R; Zhou M; Argani P; Delahunt B; Berney DM; Srigley JR; Tickoo S; Reuter VE
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2014;38(8):e35-e49
Best Practices Recommendations in the Application of Immunohistochemistry in the Kidney Tumors Report From the International Society of Urologic Pathology Consensus Conference
Reuter VE; Argani P; Zhou M; Delahunt B
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2014;38(8):1017-1022
Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology Report From the International Society of Urological Pathology Consensus Conference
Amin MB; Epstein JI; Ulbright TM; Humphrey PA; Egevad L; Montironi R; Grignon D; Trpkov K; Lopez-Beltran A; Zhou M; Argani P; Delahunt B; Berney DM; Srigley JR; Tickoo SK; Reuter VE
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2014;38(8):e50-e59
Best Practices Recommendations in the Application of Immunohistochemistry in Testicular Tumors Report From the International Society of Urological Pathology Consensus Conference
Ulbright TM; Tickoo SK; Berney DM; Srigley JR; Amin MB; Epstein JI; Humphrey PA; Egevad L; Montironi R; Grignon D; Trpkov K; Lopez-Beltran A; Zhou M; Argani P; Delahunt B; Reuter VE
Article: CANCER RESEARCH. 2014;74(13):3408-3417
Local and Systemic Protumorigenic Effects of Cancer-Associated Fibroblast-Derived GDF15
Bruzzese F; Hagglof C; Leone A; Sjoberg E; Roca MS; Kiflemariam S; Sjoblom T; Hammarsten P; Egevad L; Bergh A; Ostman A; Budillon A; Augsten M
Article: EUROPEAN JOURNAL OF CANCER. 2014;50(10):1829-1835
High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome
Tidehag V; Hammarsten P; Egevad L; Grantors T; Stattin P; Leanderson T; Wikstrom P; Josefsson A; Hagglof C; Bergh A
Article: EUROPEAN UROLOGY. 2014;65(6):1184-1190
A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1-3 ng/ml
Nordstrom T; Aly M; Eklund M; Egevad L; Gronberg H
Article: UROLOGY. 2014;83(5):969-974
Advances in Renal Neoplasia
Delahunt B; Srigley JR; Montironi R; Egevad L
Article: VIRCHOWS ARCHIV. 2014;464(5):583-587
Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists
Berney DM; Algaba F; Camparo P; Comperat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Montironi R; Varma M; Egevad L
Article: CLINICAL CANCER RESEARCH. 2014;20(8):2169-2181
Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy
Kristensen H; Haldrup C; Strand S; Mundbjerg K; Mortensen MM; Thorsen K; Ostenfeld MS; Wild PJ; Arsov C; Goering W; Visakorpi T; Egevad L; Lindberg J; Groenberg H; Hoyer S; Borre M; Orntoft TF; Sorensen KD
Article: PLOS ONE. 2014;9(2):e86824
TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
Hagglof C; Hammarsten P; Stromvall K; Egevad L; Josefsson A; Stattin P; Granfors T; Bergh A
Article: NATURE GENETICS. 2014;46(2):126-135
A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding
Huang Q; Whitington T; Gao P; Lindberg JF; Yang Y; Sun J; Vaisanen M-R; Szulkin R; Annala M; Yan J; Egevad LA; Zhang K; Lin R; Jolma A; Nykter M; Manninen A; Wiklund F; Vaarala MH; Visakorpi T; Xu J; Taipale J; Wei G-H
Article: HISTOPATHOLOGY. 2014;64(3):405-411
The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists
Berney DM; Algaba F; Camparo P; Comperat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Montironi R; Varma M; Egevad L
Article: PATHOLOGY. 2014;46(1):11-14
Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men
Samaratunga H; Delahunt B; Yaxley J; Perry-Keene J; Lamb DS; Srigley JR; Egevad L; Nacey JN
Article: CARCINOGENESIS. 2014;35(1):24-33
SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer
Iglesias-Gato D; Chuan Y-C; Wikstrom P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
Article: HISTOPATHOLOGY. 2013;63(6):756-766
An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps
Comperat E; Egevad L; Lopez-Beltran A; Camparo P; Algaba F; Amin M; Epstein JI; Hamberg H; Hulsbergen-van de Kaa C; Kristiansen G; Montironi R; Pan C-C; Heloir F; Treurniet K; Sykes J; Van der Kwast TH
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2013;37(10):1469-1489
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
Srigley JR; Delahunt B; Eble JN; Egevad L; Epstein JI; Grignon D; Hes O; Moch H; Montironi R; Tickoo SK; Zhou M; Argani P
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2013;37(10):1518-1531
Renal Tumors Diagnostic and Prognostic Biomarkers
Tan PH; Cheng L; Rioux-Leclercq N; Merino MJ; Netto G; Reuter VE; Shen SS; Grignon DJ; Montironi R; Egevad L; Srigley JR; Delahunt B; Moch H
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2013;37(10):1505-1517
Handling and Staging of Renal Cell Carcinoma The International Society of Urological Pathology Consensus (ISUP) Conference Recommendations
Trpkov K; Grignon DJ; Bonsib SM; Amin MB; Billis A; Lopez-Beltran A; Samaratunga H; Tamboli P; Delahunt B; Egevad L; Montironi R; Srigley JR
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2013;37(10):1490-1504
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
Delahunt B; Cheville JC; Martignoni G; Humphrey PA; Magi-Galluzzi C; McKenney J; Egevad L; Algaba F; Moch H; Grignon DJ; Montironi R; Srigley JR
Article: HISTOPATHOLOGY. 2013;63(4):580-589
Prognostic significance of histopathological features of extraprostatic extension of prostate cancer
Danneman D; Wiklund F; Wiklund NP; Egevad L
Article: CANCER. 2013;119(13):2405-2412
Genetic markers associated with early cancer-specific mortality following prostatectomy
Liu W; Xie CC; Thomas CY; Kim S-T; Lindberg J; Egevad L; Wang Z; Zhang Z; Sun J; Sun J; Koty PP; Kader AK; Cramer SD; Bova GS; Zheng SL; Groenberg H; Isaacs WB; Xu J
Article: ANNALES DE PATHOLOGIE. 2013;33(3):155-161
International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens
Comperat E; Camparo P; Srigley J; Delahunt B; Egevad L; Amin M; Berney DM; Billis A; Cheng L; Epstein J; Evans A; Grignon D; Humphrey P; Magi-Galuzzi C; Montironi R; Samaratunga H; Tan PH; True L; van der Kwast T; Wheeler T
Article: HISTOPATHOLOGY. 2013;62(7):1049-1056
Prognostic significance of patterns of seminal vesicle invasion in prostate cancer
Kristiansen A; Wiklund F; Wiklund P; Egevad L
Article: EUROPEAN UROLOGY. 2013;63(4):702-708
The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer
Lindberg J; Mills IG; Klevebring D; Liu W; Neiman M; Xu J; Wikstrom P; Wiklund P; Wiklund F; Egevad L; Gronberg H
Article: PATHOLOGY. 2013;45(3):243-250
Premalignant lesions of the urinary bladder
Samaratunga H; Martignoni G; Egevad L; Delahunt B
Article: VIRCHOWS ARCHIV. 2013;462(4):429-436
Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens
Seipel AH; Wiklund F; Wiklund NP; Egevad L
Article: CLINICAL CANCER RESEARCH. 2013;19(6):1547-1556
Castration Therapy Results in Decreased Ku70 Levels in Prostate Cancer
Al-Ubaidi FLT; Schultz N; Loseva O; Egevad L; Granfors T; Helleday T
Article: HUMAN PATHOLOGY. 2013;44(3):310-319
Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy
Mirtti T; Leiby BE; Abdulghani J; Aaltonen E; Pavela M; Mamtani A; Alanen K; Egevad L; Granfors T; Josefsson A; Stattin P; Bergh A; Nevalainen MT
Article: JOURNAL OF CLINICAL PATHOLOGY. 2013;66(2):120-123
Prostate needle biopsy processing: a survey of laboratory practice across Europe
Varma M; Berney DM; Algaba F; Camparo P; Comperat E; Griffiths DFR; Kristiansen G; Lopez-Beltran A; Montironi R; Egevad L
Article: EUROPEAN UROLOGY. 2013;63(2):347-353
Exome Sequencing of Prostate Cancer Supports the Hypothesis of Independent Tumour Origins
Lindberg J; Klevebring D; Liu W; Neiman M; Xu J; Wiklund P; Wiklund F; Mills IG; Egevad L; Gronberg H
Article: HISTOPATHOLOGY. 2013;62(2):247-256
Standardization of Gleason grading among 337 European pathologists
Egevad L; Ahmad AS; Algaba F; Berney DM; Boccon-Gibod L; Comperat E; Evans AJ; Griffiths D; Grobholz R; Kristiansen G; Langner C; Lopez-Beltran A; Montironi R; Moss S; Oliveira P; Vainer B; Varma M; Camparo P
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2012;46(6):405-410
Current routines for transrectal ultrasound-guided prostate biopsy: A web-based survey by the Swedish Urology Network
Carlsson S; Bratt O; Stattin P; Egevad L
Article: EUROPEAN JOURNAL OF CANCER. 2012;48(17):3267-3277
Fruit and vegetable consumption and risk of aggressive and non-aggressive urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition
Ros MM; Bueno-de-Mesquita HB; Kampman E; Buchner FL; Aben KKH; Egevad L; Overvad K; Tjonneland A; Roswall N; Clavel-Chapelon F; Boutron-Ruault MC; Morois S; Kaaks R; Teucher B; Weikert S; von Ruesten A; Trichopoulou A; Naska A; Benetou V; Saieva C; Pala V; Ricceri F; Tumino R; Mattiello A; Peeters PHM; van Gils CH; Gram IT; Engeset D; Chirlaque M-D; Ardanazx E; Rodriguez L; Amanio P; Gonzalez CA; Jose Sanchez M; Ulmert D; Ernstrom R; Ljungberg B; Allen NE; Key TJ; Khaw K-T; Wareham N; Slimani N; Romieu I; Kiemeney LA; Riboli E
Article: EUROPEAN UROLOGY. 2012;62(5):768-774
Biochemical Recurrence After Robot-assisted Radical Prostatectomy in a European Single-centre Cohort with a Minimum Follow-up Time of 5 Years
Sooriakumaran P; Haendler L; Nyberg T; Gronberg H; Nilsson A; Carlsson S; Hosseini A; Adding C; Jonsson M; Ploumidis A; Egevad L; Steineck G; Wiklund P
Article: PLOS ONE. 2012;7(10):e48455
Identification of New Differentially Methylated Genes That Have Potential Functional Consequences in Prostate Cancer
Kim JW; Kim S-T; Turner AR; Young T; Smith S; Liu W; Lindberg J; Egevad L; Gronberg H; Isaacs WB; Xu J
Article: PLOS ONE. 2012;7(10):e47994
Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression
Hammarsten P; Cipriano M; Josefsson A; Stattin P; Egevad L; Granfors T; Fowler CJ
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2012;96(4):902-910
Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition
Ros MM; Bueno-de-Mesquita HB; Kampman E; Aben KKH; Buechner FL; Jansen EHJM; van Gils CH; Egevad L; Overvad K; Tjonneland A; Roswall N; Boutron-Ruault MC; Kvaskoff M; Perquier F; Kaaks R; Chang-Claude J; Weikert S; Boeing H; Trichopoulou A; Lagiou P; Dilis V; Palli D; Pala V; Sacerdote C; Tumino R; Panico S; Peeters PHM; Gram IT; Skeie G; Huerta JM; Barricarte A; Quiros JR; Sanchez MJ; Buckland G; Larranaga N; Ehrnstroem R; Wallstroem P; Jungberg BL; Hallmans G; Key TJ; Allen NE; Khaw K-T; Wareham N; Brennan P; Riboli E; Kiemeney LA
Article: ONCOGENE. 2012;31(35):3939-3948
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer
Liu W; Lindberg J; Sui G; Luo J; Egevad L; Li T; Xie C; Wan M; Kim S-T; Wang Z; Turner AR; Zhang Z; Feng J; Yan Y; Sun J; Bova GS; Ewing CM; Yan G; Gielzak M; Cramer SD; Vessella RL; Zheng SL; Gronberg H; Isaacs WB; Xu J
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2012;46(4):247-257
Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance
Josefsson A; Wikstrom P; Egevad L; Granfors T; Karlberg L; Stattin P; Bergh A
Article: CANCER MEDICINE. 2012;1(1):96-104
Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer
Khaja ASS; Egevad L; Helczynski L; Wiklund P; Andersson T; Bjartell A
Article: PATHOLOGE. 2012;33(4):337-344
Diagnostics of radical prostatectomy specimens. Results of the 2009 consensus conference of the International Society of Urological Pathology
Kristiansen G; Srigley JR; Delahunt B; Egevad L
Article: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2012;136(4):426-434
Implications of the International Society of Urological Pathology Modified Gleason Grading System
Egevad L; Mazzucchelli R; Montironi R
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2012;82(3):1243-1248
CASTRATION THERAPY OF PROSTATE CANCER RESULTS IN DOWNREGULATION OF HIF-1α LEVELS
Al-Ubaidi FLT; Schultz N; Egevad L; Granfors T; Helleday T
Article: JOURNAL OF CLINICAL PATHOLOGY. 2012;65(2):106-113
Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology
Algaba F; Delahunt B; Berney DM; Camparo P; Comperat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Martignoni G; Moch H; Montironi R; Varma M; Egevad L
Article: CELL DEATH & DISEASE. 2012;3(1):e262
Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
Kharaziha P; Rodriguez P; Li Q; Rundqvist H; Bjoerklund A-C; Augsten M; Ullen A; Egevad L; Wiklund P; Nilsson S; Kroemer G; Grander D; Panaretakis T
Article: AMERICAN JOURNAL OF PATHOLOGY. 2011;179(4):1961-1968
Prostate Cancer Increases Hyaluronan in Surrounding Nonmalignant Stroma, and This Response Is Associated with Tumor Growth and an Unfavorable Outcome
Josefsson A; Adamo H; Hammarsten P; Granfors T; Stattin P; Egevad L; Laurent AE; Wikstrom P; Bergh A
Article: PATHOLOGY INTERNATIONAL. 2011;61(9):536-538
Solitary fibrous tumor of the prostate: A report of two cases
Talvitie H; Astrom K; Larsson O; Ahlen J; Bergh A; Egevad L
Article: VIRCHOWS ARCHIV. 2011;459(2):175-182
Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading
Egevad L; Algaba F; Berney DM; Boccon-Gibod L; Comperat E; Evans AJ; Grobholz R; Kristiansen G; Langner C; Lockwood G; Lopez-Beltran A; Montironi R; Oliveira P; Schwenkglenks M; Vainer B; Varma M; Verger V; Camparo P
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(12):2843-2852
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer
Thomasson M; Wang B; Hammarsten P; Dahlman A; Persson JL; Josefsson A; Stattin P; Granfors T; Egevad L; Henriksson R; Bergh A; Hedman H
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(12):2971-2979
Variety in vegetable and fruit consumption and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition
Buchner FL; Bueno-de-Mesquita HB; Ros MM; Kampman E; Egevad L; Overvad K; Tjonneland A; Roswall N; Clavel-Chapelon F; Boutron-Ruault M-C; Touillaud M; Kaaks R; Chang-Claude J; Boeing H; Weikert S; Trichopoulou A; Naska A; Benetou V; Palli D; Sieri S; Vineis P; Tumino R; Panico S; van Duijnhoven FJB; Peeters PHM; van Gils CH; Lund E; Gram IT; Sanchez M-J; Jakszyn P; Larranaga N; Ardanaz E; Navarro C; Rodriguez L; Manjer J; Ehrnstrom R; Hallmans G; Ljungberg B; Key TJ; Allen NE; Khaw K-T; Wareham N; Slimani N; Jenab M; Boffetta P; Kiemeney LALM; Riboli E
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(11):2695-2708
Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Ros MM; Bueno-de-Mesquita HBB; Buchner FL; Aben KKH; Kampman E; Egevad L; Overvad K; Tjonneland A; Roswall N; Clavel-Chapelon F; Kaaks R; Chang-Claude J; Boeing H; Weikert S; Trichopoulou A; Orfanos P; Stasinopulou G; Saieva C; Krogh V; Vineis P; Tumino R; Mattiello A; Peeters PHM; van Duijnhoven FJB; Lund E; Gram IT; Chirlaque MD; Barricarte A; Rodriguez L; Molina E; Gonzalez C; Dorronsoro M; Manjer J; Ehrnstrom R; Ljungberg B; Allen NE; Roddam AW; Khaw K-T; Wareham N; Boffetta P; Slimani N; Michaud DS; Kiemeney LALM; Riboli E
Article: HISTOPATHOLOGY. 2011;58(4):579-585
Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP)
Lopez-Beltran A; Algaba F; Berney DM; Boccon-Gibod L; Camparo P; Griffiths D; Mikuz G; Montironi R; Varma M; Egevad L
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2011;20(3):555-559
Red Meat, Dietary Nitrosamines, and Heme Iron and Risk of Bladder Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Jakszyn P; Gonzalez CA; Lujan-Barroso L; Ros MM; Bueno-de-Mesquita HB; Roswall N; Tjonneland AM; Buchner FL; Egevad L; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Boutron-Ruault M-C; Touillaud MS; Chang-Claude J; Allen NE; Kiemeney LA; Key TJ; Kaaks R; Boeing H; Weikert S; Trichopoulou A; Oikonomou E; Zylis D; Palli D; Berrino F; Vineis P; Tumino R; Mattiello A; Peeters PHM; Parr CL; Gram IT; Skeie G; Sanchez M-J; Larranaga N; Ardanaz E; Navarro C; Rodriguez L; Ulmert D; Ehrnstrom R; Hallmans G; Ljungberg B; Roddam AW; Bingham SA; Khaw K-T; Slimani N; Boffetta PA; Jenab M; Mouw T; Michaud DS; Riboli E
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2011;45(1):39-45
GAD1 is a biomarker for benign and malignant prostatic tissue
Jaraj SJ; Augsten M; Haggarth L; Wester K; Ponten F; Ostman A; Egevad L
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2011;45(1):60-67
Diagnostic biomarkers of prostate cancer
Haggarth L; Hagglof C; Jaraj SJ; Wester K; Ponten F; Ostman A; Egevad L
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2010;44(6):371-377
Beta-tubulin III expression in prostate cancer
Egevad L; Valdman A; Wiklund NP; Seve P; Dumontet C
Article: JOURNAL OF UROLOGY. 2010;184(4):1322-1327
Outcome of Primary Versus Deferred Radical Prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study
Holmstrom B; Holmberg E; Egevad L; Adolfsson J; Johansson J-E; Hugosson J; Stattin P
Article: PLOS ONE. 2010;5(8):e12275
Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB₁ Receptor Expression and Regulation by IL-4
Thors L; Bergh A; Persson E; Hammarsten P; Stattin P; Egevad L; Granfors T; Fowler CJ
Article: AMERICAN JOURNAL OF PATHOLOGY. 2010;177(2):1031-1041
Mast Cells Are Novel Independent Prognostic Markers in Prostate Cancer and Represent a Target for Therapy
Johansson A; Rudolfsson S; Hammarsten P; Halin S; Pietras K; Jones J; Stattin P; Egevad L; Granfors T; Wikstrom P; Bergh A
Article: CARCINOGENESIS. 2010;31(8):1475-1482
Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein
Gouas DA; Shi H; Hautefeuille AH; Ortiz-Cuaran SL; Legros PC; Szymanska KJ; Galy O; Egevad LA; Abedi-Ardekani B; Wiman KG; Hantz O; de Fromentel CC; Chemin IA; Hainaut PL
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2010;102(13):950-958
Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study
Stattin P; Holmberg E; Johansson J-E; Holmberg L; Adolfsson J; Hugosson J
Article: APMIS. 2010;118(5):383-388
Formalin fixation and immunoreactivity in prostate cancer and benign prostatic tissues
Jaraj SJ; Egevad L
Article: APMIS. 2010;118(5):360-365
Distribution of Foxp3-, CD4-and CD8-positive lymphocytic cells in benign and malignant prostate tissue
Valdman A; Jaraj SJ; Comperat E; Charlotte F; Roupret M; Pisa P; Egevad L
Article: NATURE. 2010;464(7291):993-998
International network of cancer genome projects
Hudson TJ; Anderson W; Aretz A; Barker AD; Bell C; Bernabe RR; Bhan MK; Calvo F; Eerola I; Gerhard DS; Guttmacher A; Guyer M; Hemsley FM; Jennings JL; Kerr D; Klatt P; Kolar P; Kusuda J; Lane DP; Laplace F; Lu Y; Nettekoven G; Ozenberger B; Peterson J; Rao TS; Remacle J; Schafer AJ; Shibata T; Stratton MR; Vockley JG; Watanabe K; Yang H; Yuen MMF; Knoppers M; Bobrow M; Cambon-Thomsen A; Dressler LG; Dyke SOM; Joly Y; Kato K; Kennedy KL; Nicolas P; Parker MJ; Rial-Sebbag E; Romeo-Casabona CM; Shaw KM; Wallace S; Wiesner GL; Zeps N; Lichter P; Biankin AV; Chabannon C; Chin L; Clement B; de Alava E; Degos F; Ferguson ML; Geary P; Hayes DN; Johns AL; Nakagawa H; Penny R; Piris MA; Sarin R; Scarpa A; van de Vijver M; Futreal PA; Aburatani H; Bayes M; Bowtell DDL; Campbell PJ; Estivill X; Grimmond SM; Gut I; Hirst M; Lopez-Otin C; Majumder P; Marra M; Ning Z; Puente XS; Ruan Y; Stunnenberg HG; Swerdlow H; Velculescu VE; Wilson RK; Xue HH; Yang L; Spellman PT; Bader GD; Boutros PC; Flicek P; Getz G; Guigo R; Guo G; Haussler D; Heath S; Hubbard TJ; Jiang T; Jones SM; Li Q; Lopez-Bigas N; Luo R; Pearson JV; Quesada V; Raphael BJ; Sander C; Speed TP; Stuart JM; Teague JW; Totoki Y; Tsunoda T; Valencia A; Wheeler DA; Wu H; Zhao S; Zhou G; Stein LD; Lathrop M; Ouellette BFF; Thomas G; Yoshida T; Axton M; Gunter C; McPherson JD; Miller LJ; Kasprzyk A; Zhang J; Haider SA; Wang J; Yung CK; Cross A; Liang Y; Gnaneshan S; Guberman J; Hsu J; Chalmers DRC; Hasel KW; Kaan TSH; Knoppers BM; Lowrance WW; Masui T; Rodriguez LL; Vergely C; Cloonan N; Defazio A; Eshleman JR; Etemadmoghadam D; Gardiner BA; Kench JG; Sutherland RL; Tempero MA; Waddell NJ; Wilson PJ; Gallinger S; Tsao M-S; Shaw PA; Petersen GM; Mukhopadhyay D; DePinho RA; Thayer S; Muthuswamy L; Shazand K; Beck T; Sam M; Timms L; Ballin V; Ji J; Zhang X; Chen F; Hu X; Yang Q; Tian G; Zhang L; Xing X; Li X; Zhu Z; Yu Y; Yu J; Tost J; Brennan P; Holcatova I; Zaridze D; Brazma A; Egevad L; Prokhortchouk E; Banks RE; Uhlen M; Viksna J; Ponten F; Skryabin K; Birney E; Borg A; Borresen-Dale A-L; Caldas C; Foekens JA; Martin S; Reis-Filho JS; Richardson AL; Sotiriou C; van't Veer L; Birnbaum D; Blanche H; Boucher P; Boyault S; Masson-Jacquemier JD; Pauporte I; Pivot X; Vincent-Salomon A; Tabone E; Theillet C; Treilleux I; Bioulac-Sage P; Decaens T; Franco D; Gut M; Samuel D; Zucman-Rossi J; Eils R; Brors B; Korbel JO; Korshunov A; Landgraf P; Lehrach H; Pfister S; Radlwimmer B; Reifenberger G; Taylor MD; von Kalle C; Majumder PP; Pederzoli P; Lawlor RT; Delledonne M; Bardelli A; Gress T; Klimstra D; Zamboni G; Nakamura Y; Miyano S; Fujimoto A; Campo E; de Sanjose S; Montserrat E; Gonzalez-Diaz M; Jares P; Himmelbaue H; Bea S; Aparicio S; Easton DF; Collins FS; Compton CC; Lander ES; Burke W; Green AR; Hamilton SR; Kallioniemi OP; Ley TJ; Liu ET; Wainwright BJ
Article: CLINICAL CANCER RESEARCH. 2010;16(4):1245-1255
Low Levels of Phosphorylated Epidermal Growth Factor Receptor in Nonmalignant and Malignant Prostate Tissue Predict Favorable Outcome in Prostate Cancer Patients
Hammarsten P; Karalija A; Josefsson A; Rudolfsson SH; Wikstrom P; Egevad L; Granfors T; Stattin P; Bergh A
Article: CELLULAR ONCOLOGY. 2010;32(1):39-44
Clinical Significance of Intratumoral CD8+ Regulatory T Cells in Prostate Carcinoma
Comperat E; Egevad L; Camparo P; Roupret M; Vaessen C; Valdman A; Jonmarker S; Capron F; Cussenot O; Charlotte F
Article: CELLULAR ONCOLOGY. 2009;31(6):367-374
Expression of Redox Pathway Enzymes in Human Prostatic Tissue
Valdman A; Haggarth L; Cheng L; Lopez-Beltran A; Montironi R; Ekman P; Egevad L
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;125(11):2643-2651
Consumption of vegetables and fruit and the risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition
Buechner FL; Bueno-de-Mesquita HB; Ros MM; Kampman E; Egevad L; Overvad K; Raaschou-Nielsen O; Tjonneland A; Roswall N; Clavel-Chapelon F; Boutron-Ruault M-C; Touillaud M; Chang-Claude J; Kaaks R; Boeing H; Weikert S; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Vineis P; Tumino R; Panico S; Vrieling A; Peeters PHM; van Gils CH; Lund E; Gram IT; Engeset D; Martinez C; Gonzalez CA; Larranaga N; Ardanaz E; Navarro C; Rodriguez L; Manjer J; Ehrnstrom RA; Hallmans G; Ljungberg B; Allen NE; Roddam AW; Bingham S; Khaw K-T; Slimani N; Boffetta P; Jenab M; Mouw T; Michaud DS; Kiemeney LALM; Riboli E
Article: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2009;133(10):1568-1576
Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland
Srigley JR; Humphrey PA; Amin MB; Chang SS; Egevad L; Epstein JI; Grignon DJ; McKiernan JM; Montironi R; Renshaw AA; Reuter VE; Wheeler TM
Article: VIRCHOWS ARCHIV. 2009;455(4):375-381
Intra- and interobserver reproducibility of interpretation of immunohistochemical stains of prostate cancer
Jaraj SJ; Camparo P; Boyle H; Germain F; Nilsson B; Petersson F; Egevad L
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;125(4):902-908
Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
Johnsen NF; Tjonneland A; Thomsen BLR; Christensen J; Loft S; Friedenreich C; Key TJ; Allen NE; Lahmann PH; Mejlvig L; Overvad K; Kaaks R; Rohrmann S; Boing H; Misirli G; Trichopoulou A; Zylis D; Tumino R; Pala V; Bueno-de-Mesquita HB; Kiemeney LA; Rodriguez Suarez L; Gonzalez CA; Sanchez M-J; Maria Huerta J; Barricarte Gurrea A; Manjer J; Wirfalt E; Khaw K-T; Wareham N; Boffetta P; Egevad L; Rinaldi S; Riboli E
Article: CELLULAR ONCOLOGY. 2009;31(3):137-142
Endothelin-1 Expression in Prostate Cancer and High Grade Prostatic Intraepithelial Neoplasia
Rosenblatt R; Valdman A; Cheng L; Lopez-Beltran A; Montironi R; Ekman P; Egevad L
Article: CELLULAR ONCOLOGY. 2009;31(2):90-95
The European Network of Uropathology A Novel Mechanism for Communication Between Pathologists
Egevad L; Algaba F; Berney DM; Boccon-Gibod L; Griffiths DF; Lopez-Beltran A; Mikuz G; Varma M; Montironi R
Article: CELLULAR ONCOLOGY. 2009;31(2):74-82
Expression of Immunomodulating Genes in Prostate Cancer and Benign Prostatic Tissue
Reschner A; Harlin H; Laven B; Eriksson F; Pisa P; Egevad L
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(9):3414-3419
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
Augsten M; Hagglof C; Olsson E; Stolz C; Tsagozis P; Levchenko T; Frederick MJ; Borg A; Micke P; Egevad L; Ostman A
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2009;43(1):88-91
Urachal signet-cell adenocarcinoma
Egevad L; Hakansson U; Grabe M; Ehrnstrom R
Article: EUROPEAN JOURNAL OF CANCER. 2009;45(1):174-182
A high cannabinoid CB₁ receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
Chung SC; Hammarsten P; Josefsson A; Stattin P; Granfors T; Egevad L; Mancini G; Lutz B; Bergh A; Fowler CJ
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(1):245-249
A prospective analysis of the association between dietary fiber intake and prostate cancer risk in EPIC
Suzuki R; Allen NE; Key TJ; Appleby PN; Tjonneland A; Johnsenz NF; Jensen MK; Overvad K; Boeing H; Pischon T; Kaaks R; Rohrmann S; Trichopoulou A; Misirli G; Trichopoulos D; Bueno-de-Mesquita HB; van Duijnhoven F; Sacerdote C; Pala V; Palli D; Tumino R; Ardanaz E; Quiros JR; Larranaga N; Sanchez M-J; Tormo M-J; Jakszyn P; Johansson I; Stattin P; Berglund G; Manjer J; Bingham S; Khaw K-T; Egevad L; Ferrari P; Jenab M; Riboli E
Article: APMIS. 2008;116(10):888-895
Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer
Glaessgen A; Jonmarker S; Lindberg A; Nilsson B; Lewensohn R; Ekman P; Valdman A; Egevad L
Article: CELLULAR ONCOLOGY. 2008;30(5):254-260
Recent Trends in Gleason Grading of Prostate Cancer II. Prognosis, Reproducibility and Reporting
Egevad L
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2008;32(10):1532-1539
Grading of invasive cribriform carcinoma on prostate needle biopsy - An interobserver study among experts in genitourinary pathology
Latour M; Amin MB; Billis A; Egevad L; Grignon DJ; Humphrey PA; Reuter VE; Sakr WA; Srigley JR; Wheeler TM; Yang XJ; Epstein JI
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2008;32(10):1503-1512
Interobserver variability between expert: Urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens
Evans AJ; Henry PC; Van der Kwast TH; Tkachuk DC; Watson K; Lockwood GA; Fleshner NE; Cheung C; Belanger EC; Amin MB; Boccon-Gibod L; Bostwick DG; Egevad L; Epstein JI; Grignon DJ; Jones EC; Montironi R; Moussa M; Sweet JM; Trpkov K; Wheeler TM; Srigley JR
Article: HISTOPATHOLOGY. 2008;53(3):333-339
Handling and reporting of radical prostatectomy specimens in Europe: a web-based survey by the European Network of Uropathology (ENUP)
Egevad L; Algaba F; Berney DM; Boccon-Gibod L; Griffiths DF; Lopez-Beltran A; Mikuz G; Varma M; Montironi R
Article: AMERICAN JOURNAL OF CLINICAL PATHOLOGY. 2008;130(3):375-381
Quantitative assessment of the subepithelial collagen band does not increase the accuracy of diagnosis of collagenous colitis
Rubio CA; Orrego A; Hoog A; Porwitz A; F'etersson F; Elmberger G; Glaessgen A; Eriksson E; Kanter L; Jaremko G; Egevad L; Laforga J; Liljefors M; Lofdahl B; Norman P; Larsson O; Wanat R; Wejde J; Zickert P; Bjork J; Caini S; Palli D; Nesi G
Article: CELLULAR ONCOLOGY. 2008;30(4):190-198
Recent trends in Gleason grading of prostate cancer - I. Pattern interpretation
Egevad L
Article: APMIS. 2008;116(6):491-498
Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue
Jonmarker S; Glaessgen A; Culp WD; Pisa P; Lewensohn R; Ekman P; Valdman A; Egevad L
Article: CELLULAR ONCOLOGY. 2008;30(3):133-138
Correlation of modified gleason grading of prostate carcinoma with age, serum prostate specific antigen and tumor extent in needle biopsy specimens
Helpap B; Egevad L
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2008;17(5):1282-1287
Alcohol consumption and the risk for prostate cancer in the European prospective investigation into cancer and nutrition
Rohrmann S; Linseisen J; Key TJ; Jensen MK; Overvad K; Johnsen NF; Tjonneland A; Kaaks R; Bergmann MM; Weikert C; Naska A; Trichopoulou A; Trichopoulos D; Pala V; Sacerdote C; Palli D; Tumino R; Bueno-de-Mesquita HB; Vrieling A; Gonzalez CA; Larranaga N; Navarro C; Barricarte A; Quiros JR; Martinez-Garcia C; Hallmans G; Stattin P; Manjer J; Wirfalt E; Bingham S; Khaw K-T; Egevad L; Ferrari P; Jenab M; Riboli E
Article: CELLULAR ONCOLOGY. 2008;30(1):1-7
Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy
Helpap B; Egevad L
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2008;17(2):279-285
Circulating concentrations of folate and vitamin B₁₂ in relation to prostate cancer risk:: Results from the European Prospective Investigation into Cancer and Nutrition study
Johansson M; Appleby PN; Allen NE; Travis RC; Roddam AW; Egevad L; Jenab M; Rinaldi S; Kiemeney LA; Bueno-de-Mesquita HB; Vollset SE; Ueland PM; Sanchez M-J; Quiros JR; Gonzalez CA; Larranaga N; Chirlaque MD; Ardanaz E; Sieri S; Palli D; Vineis P; Tumino R; Linseisen J; Kaaks R; Boeing H; Pischon T; Psaltopouiou T; Trichopouiou A; Trichopoulos D; Khaw K-T; Bingham S; Hallmans G; Riboli E; Stattin P; Key TJ
Article: BJU INTERNATIONAL. 2008;101(3):293-298
Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer
Braeckman J; Autier P; Garbar C; Marichal MP; Soviany C; Nir R; Nir D; Michielsen D; Bleiberg H; Egevad L; Emberton M
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2008;42(5):484-487
Atypical stromal hyperplasia of the prostate
Egevad L; Carbin B-E; Castellanos E; Hellstrom M; Valdman A
Article: INTERNATIONAL JOURNAL OF CANCER. 2007;121(6):1331-1338
Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition
Travis RC; Key TJ; Allen NE; Appleby PN; Roddam AW; Rinaldi S; Egevad L; Gann PH; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjonneland A; Overvad K; Kiemeney L; Bueno-de-Mesquitalo HB; Bingham S; Khaw K-T; Tumino R; Sieri S; Vineis P; Palli D; Quiros JR; Ardanaz E; Chirlaque M-D; Larranaga N; Gonzalez C; Sanchez M-J; Trichopoulou A; Bikou C; Trichopoulos D; Stattin P; Jenab M; Ferrari P; Slimani N; Riboli E; Kaaks R
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2007;86(3):672-681
Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study
Key TJ; Appleby PN; Allen NE; Travis RC; Roddam AW; Jenab M; Egevad L; Tionneland A; Johnsen NF; Overvad K; Linseisen J; Rohrmann S; Boeing H; Pischon T; Psaltopoulou T; Trichopoulou A; Trichopoulos D; Palli D; Vineis P; Tumino R; Berrino F; Kiemeney L; Bueno-de-Mesquita HB; Quiros JR; Gonzalez CA; Martinez C; Larranaga N; Chirlaque MD; Ardanaz E; Stattin P; Hallmans G; Khaw K-T; Bingham S; Slimani N; Ferrari P; Rinaldi S; Riboli E
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2007;16(6):1121-1127
Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk:: Results from the European prospective investigation into cancer and nutrition
Allen NE; Key TJ; Appleby PN; Travis RC; Roddam AW; Rinaldi S; Egevad L; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjonneland A; Gronbaek H; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Berrino F; Mattiello A; Sacerdote C; Palli D; Quiros JR; Ardanaz E; Navarro C; Larranaga N; Gonzalez C; Sanchez M-J; Trichopoulou A; Travezea C; Trichopoulos D; Jenab M; Ferrari P; Riboli E; Kaaks R
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2007;56(5):677-687
Tumor specific phage particles promote tumor regression in a mouse melanoma model
Eriksson F; Culp WD; Massey R; Egevad L; Garland D; Persson MAA; Pisa P
Article: UROLOGY. 2007;69(4):778.e11-778.e13
Primary seminal vesicle carcinoma detected at transurethral resection of prostate
Egevad L; Ehrnstrom R; Hakansson U; Grabe M
Article: CELLULAR ONCOLOGY. 2007;29(1):32-40
Proteomics in prostate cancer research
Hellstrom M; Lexander H; Franzen B; Egevad L
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2007;41(4):302-307
Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free:: Total PSA ratios in a consecutive series of men referred for prostate biopsies
Ryden L; Egevad L; Ekman P; Hellstrom M
Article: VIRCHOWS ARCHIV. 2006;449(6):622-627
The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens
Helpap B; Egevad L
Article: JOURNAL OF IMMUNOLOGY. 2006;177(10):7398-7405
CD4⁺CD25^high T cells are enriched in the tumor and peripheral blood of prostate cancer patients
Miller AM; Lundberg K; Ozenci V; Banham AH; Hellstrom M; Egevad L; Pisa P
Article: VIRCHOWS ARCHIV. 2006;449(3):297-301
Tissue shrinkage after fixation with formalin injection of prostatectomy specimens
Jonmarker S; Valdman A; Lindberg A; Hellstrom M; Egevad L
Article: PROTEOMICS. 2006;6(15):4370-4380
Correlation of protein expression, Gleason score and DNA ploidy in prostate cancer
Lexander H; Palmberg C; Hellman U; Auer G; Hellstrom M; Franzen B; Jornvall H; Egevad L
Article: PROTEOMICS. 2006;6(13):3918-3925
Evaluation of two sample preparation methods for prostate proteome analysis
Lexander H; Hellman U; Palmberg C; Auer G; Hellstrom M; Franzen B; Jornvall H; Egevad L
Article: JOURNAL OF PROTEOME RESEARCH. 2006;5(6):1332-1343
Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model
Culp WD; Neal R; Massey R; Egevad L; Pisa P; Garland D
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(10):2485-2489
Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor
Fang XL; Liu ZX; Fan YD; Zheng CY; Nilson S; Egevad L; Ekman P; Xu DW
Article: DIAGNOSTIC CYTOPATHOLOGY. 2006;34(5):317-322
Cytological features of prostatic intraepithelial neoplasia
Valdman A; Jonmarker S; Ekman P; Egevad L
Article: HUMAN PATHOLOGY. 2006;37(3):292-297
Current practice of diagnosis and reporting of prostate cancer on needle biopsy among genitourinary pathologists
Egevad L; Allsbrook WCJ; Epstein JI
Article: MODERN PATHOLOGY. 2006;19(2):180-185
Current practice of diagnosis and reporting of prostatic intraepithelial neoplasia and glandular atypia among genitourinary pathologists
Egevad L; Allsbrook WCJ; Epstein JI
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2006;40(6):465-471
Prediction of percent Gleason grade 4/5 by multiple core biopsies
Glaessgen A; Busch C; Norberg M; Haggman M; Nilsson B; Egevad L
Article: EUROPEAN UROLOGY. 2005;48(5):852-857
Ezrin expression in prostate cancer and benign prostatic tissue
Valdman A; Fang XL; Pang ST; Nilsson B; Ekman P; Egevad L
Article: EUROPEAN UROLOGY. 2005;48(4):577-583
Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment
Josefsson A; Wikström P; Granfors T; Egevad L; Karlberg L; Stattin P; Bergh A
Article: CELLULAR ONCOLOGY. 2005;27(5):263-272
Proteomic analysis of protein expression in prostate cancer
Lexander H; Palmberg C; Auer G; Hellström M; Franzén B; Jörnvall H; Egevad L
Article: PROSTATE. 2005;65(1):20-26
Presence and specificity of tumor associated lymphocytes from ascites fluid in prostate cancer
Ozenci V; Miller AM; Palmborg A; Egevad L; Jaremko GA; Kälkner KM; Pisa P
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2005;29(9):1228-1242
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
Epstein JI; Allsbrook WCJ; Amin MB; Egevad LL; Bastacky S; Beltrán AL; Berner A; Billis A; Boccon-Gibod L; Cheng L; Civantos F; Cohen C; Cohen MB; Datta M; Davis C; Delahunt B; Delprado W; Eble JN; Foster CS; Furusato M; Gaudin PB; Grignon DJ; Humphrey PA; Iczkowski KA; Jones EC; Lucia S; McCue PA; Nazeer T; Oliva E; Pan CC; Pizov G; Reuter V; Samaratunga H; Sebo T; Sesterhenn I; Shevchuk M; Srigley JR; Suzigan S; Takahashi H; Tamboli P; Tan PH; Têtu B; Tickoo S; Tomaszewski JE; Troncoso P; Tsuzuki T; True LD; van der Kwast T; Wheeler TM; Wojno KJ; Young RH
Article: PROSTATE. 2005;62(4):394-399
Angiopoietin 2 expression is related to histological grade,vascular density, metastases, and outcome in prostate cancer
Lind AJ; Wikström P; Granfors T; Egevad L; Stattin P; Bergh A
Article: PROSTATE. 2005;62(3):217-223
Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine
Roos AK; Pavlenko M; Charo J; Egevad L; Pisa P
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2005;39(5):380-386
Prediction of the volume of large prostate cancers by multiple core biopsies
Häggarth L; Busch C; Norberg M; Häggman M; Norlén BJ; Egevad L
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2005;39(5):387-392
The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer
Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L
Article: HUMAN PATHOLOGY. 2005;36(1):5-9
Current practice of Gleason grading among genitourinary pathologists
Egevad L; Allsbrook WCJ; Epstein JI
Article: PROSTATE. 2004;60(4):367-371
Pim-I expression in prostatic intraepithelial neoplasia and human prostate cancer
Valdman A; Fang XL; Pang ST; Ekman P; Egevad L
Article: BRITISH JOURNAL OF CANCER. 2004;91(4):688-694
A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer
Pavlenko M; Roos AK; Lundqvist A; Palmborg A; Miller AM; Ozenci V; Bergman B; Egevad L; Hellström M; Kiessling R; Masucci G; Wersäll P; Nilsson S; Pisa P
Article: INTERNATIONAL JOURNAL OF CANCER. 2004;109(1):119-124
Fruits and vegetables and prostate cancer:: No association among 1,104 cases in a prospective study of 130,544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Key TJ; Allen N; Appleby P; Overvad K; Tjonneland A; Miller A; Boeing H; Karalis D; Psaltopoulou T; Berrino F; Palli D; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita HB; Kiemeney L; Peeters PHM; Martinez C; Dorronsoro M; González CA; Chirlaque MD; Quiros JR; Ardanaz E; Berglund G; Egevad L; Hallmans G; Stattin P; Bingham S; Day N; Gann P; Kaaks R; Ferrari P; Riboli E
Article: UROLOGY. 2004;63(3):609-612
Expression of ezrin in prostatic intraepithelial neoplasia
Pang ST; Fang XL; Valdman A; Norstedt G; Pousette Å; Egevad L; Ekman P
Article: JOURNAL OF UROLOGY. 2004;171(2):664-667
Interobserver reproducibility of percent Gleason grade 4/5 in prostate biopsies
Glaessgen A; Hamberg H; Pihl CG; Sundelin B; Nilsson B; Egevad L
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(3):811-816
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe J; Li C; Higgins JP; van de Rijn M; Bair E; Montgomery K; Ferrari M; Egevad L; Rayford W; Bergerheim U; Ekman P; DeMarzo AM; Tibshirani R; Botstein D; Brown PO; Brooks JD; Pollack JR
Article: KIDNEY INTERNATIONAL. 2003;64(5):1671-1674
VHL down-regulation and differential localization as mechanisms in tumorigenesis
Shiao YH; Forsti A; Egevad L; Anderson LM; Lindblad P; Hemminki K
Article: VIRCHOWS ARCHIV. 2003;445(1):17-21
Interobserver reproducibility of modified Gleason score in radical prostatectomy specimens
Glaessgen A; Hamberg H; Pihl CG; Sundelin B; Nilsson B; Egevad L
Article: DIAGNOSTIC CYTOPATHOLOGY. 2003;28(5):239-244
Cytology of the central zone of the prostate
Egevad L
Article: VIRCHOWS ARCHIV. 2003;442(4):329-335
Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium
Richardsen E; Ukkonen T; Bjornsen T; Mortensen E; Egevad L; Busch C
Article: JOURNAL OF UROLOGY. 2002;168(5):2006-2010
Interobserver reproducibility of percent Gleason grade 4/5 in total prostatectomy specimens
Glaessgen A; Hamberg H; Pihl CG; Sundelin B; Nilsson B; Egevad L
Article: PROSTATE. 2002;53(3):192-199
Ultrastructure of the secretion of prostasomes from benign and malignant epithelial cells in the prostate
Sahlén GE; Egevad L; Ahlander A; Norlén BJ; Ronquist G; Nilsson BO
Article: JOURNAL OF UROLOGY. 2002;168(2):509-513
Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection
Egevad L; Granfors T; Karlberg L; Bergh A; Stattin P
Article: BJU INTERNATIONAL. 2002;90(1):51-55
A new core-biopsy instrument with an end-cut technique provides prostate biopsies with increased tissue yield
Häggarth L; Ekman P; Egevad L
Article: PROSTATE. 2002;51(4):268-275
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer
Wikström P; Lissbrandt IF; Stattin P; Egevad L; Bergh A
Article: CARCINOGENESIS. 2002;23(5):809-815
Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors
Hemminki K; Jiang YW; Ma X; Yang K; Egevad L; Lindblad P
Article: BJU INTERNATIONAL. 2002;89(6):538-542
Prognostic value of the Gleason score in prostate cancer
Egevad L; Granfors T; Karlberg L; Bergh A; Stattin P
Article: BJU INTERNATIONAL. 2001;88(7):716-721
The value of multiple core biopsies for predicting the Gleason score of prostate cancer
Egevad L; Norlén BJ; Norberg M
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2001;31(10):880-886
Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR
Finnström N; Bjelfman C; Söderström TG; Smith G; Egevad L; Norlén BJ; Wolf CR; Rane A
Article: ONCOGENE. 2001;20(38):5393-5400
VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium
Ma X; Yang K; Lindblad P; Egevad L; Hemminki K
Article: UROLOGY. 2001;57(2):291-295
Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images
Egevad L
Article: CELLULAR AND MOLECULAR LIFE SCIENCES. 2001;58(2):307-311
Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry
Alaiya AA; Oppermann M; Langridge J; Roblick U; Egevad L; Brändstedt S; Hellström M; Linder S; Bergman T; Jörnvall H; Auer G
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2001;86(2):855-858
Messenger ribonucleic acid levels of steroid 5α-reductase 2 in human prostate predict the enzyme activity
Söderström TG; Bjelfman C; Brekkan E; Ask B; Egevad L; Norlén BJ; Rane A
Article: CELLULAR ONCOLOGY. 2001;23(3-4):159-165
Automatic registration and error detection of multiple slices using landmarks
Frimmel H; Egevad L; Busch C; Bengtsson E
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2001;35(6):453-458
Relatively high risk of treatment failure after prostatectomy:: Tumour grade, histopathological stage and the preoperative serum PSA level are key prognosticators
Andersson J; Ekman P; Egevad L; Hellström M
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2000;92(23):1910-1917
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk:: a prospective study
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2000;17(3):445-451
Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival
Lissbrant IF; Stattin P; Wikström P; Damber JE; Egevad L; Bergh A
Article: CELLULAR ONCOLOGY. 2000;21(1):1-9
Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma
Alaiya A; Roblick U; Egevad L; Carlsson A; Franzén B; Volz D; Huwendiek S; Linder S; Auer G
Article: UROLOGY. 1999;54(6):1028-1034
Modeling prostate cancer distributions
Frimmel H; Egevad L; Bengtsson E; Busch C
Article: UROLOGY. 1999;54(5):862-868
Biopsy protocol stability in a three-dimensional model of prostate cancer: Changes in cancer yield after adjustment of biopsy positions
Egevad L; Frimmel H; Mattson S; Bengtsson E; Busch C
Article: CANCER LETTERS. 1999;141(1-2):1-8
Novel somatic mutations in the VHL gene in Swedish archived sporadic renal cell carcinomas
Yang K; Lindblad P; Egevad L; Hemminki K
Article: PROSTATE. 1999;39(1):36-40
Distribution of prostasomes in neoplastic epithelial prostate cells
Nilsson BO; Egevad L; Jin MS; Ronquist G; Busch C
Article: UROLOGY. 1999;53(1):192-198
Three-dimensional computer reconstruction of prostate cancer from radical prostatectomy specimens: Evaluation of the model by core biopsy simulation
Egevad L; Frimmel H; Norberg M; Mattson S; Carlbom I; Bengtsson E; Busch C
Article: UROLOGY. 1998;52(4):653-658
Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy
Egevad L; Norberg M; Mattson S; Norlén BJ; Busch C
Article: UROLOGY. 1997;50(4):562-566
The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer
Norberg M; Egevad L; Holmberg L; Sparen P; Norlen BJ; Busch C
Article: PROSTATE. 1997;32(2):99-105
Expression of p21 and mutant p53 gene products in residual prostatic tumor cells after radical radiotherapy
Ljung G; Egevad L; Norberg M; Holmberg L; Nilsson S; Busch C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1997;82(7):2210-2214
Differential gene expression of steroid 5 alpha-reductase 2 in core needle biopsies from malignant and benign prostatic tissue
Bjelfman C; Soderstrom TG; Brekkan E; Norlen BJ; Egevad L; Unge T; Andersson S; Rane A
Article: LAKARTIDNINGEN. 1997;94(26-27):2443
[More pathologists are needed in Sweden! Retirements may cause a real crisis].
Sundström C; Egevad L
Article: CELLULAR ONCOLOGY. 1997;15(3):145-156
A new method for segmentation of colour images applied to immunohistochemically stained cell nuclei
Ranefall P; Egevad L; Nordin B; Bengtsson E
Article: PROSTATE. 1996;29(5):303-310
Assessment of proliferation indicators in residual prostatic adenocarcinoma cells after radical external beam radiotherapy
Ljung G; Egevad L; Norberg M; delaTorre M; Holmberg L; Busch C; Nilsson S
Article: EUROPEAN RADIOLOGY. 1996;6(1):56-61
Multiple transrectal ultrasound-guided biopsies for the detection of prostate cancer and determination of tumor volume, grade, and seminal vesicle invasion
Norberg M; Holmberg L; Busch C; Haggman M; Egevad L; Magnusson A
Article: ACTA ONCOLOGICA. 1995;34(7):945-952
TRANSRECTAL ULTRASONICALLY-GUIDED CORE BIOPSIES IN THE ASSESSMENT OF LOCAL CURE OF PROSTATIC-CANCER AFTER RADICAL EXTERNAL-BEAM RADIOTHERAPY
LJUNG G; NORBERG M; HANSSON H; DELATORRE M; EGEVAD L; HOLMBERG L; BUSCH C; NILSSON S
Visa fler

Alla övriga publikationer

Letter: PATHOLOGY. 2025;57(6):808-809
Intraductal carcinoma of the prostate is a marker of invasive disease
Delahunt B; Samaratunga H; Egevad L
Letter: VIRCHOWS ARCHIV. 2025;487(3):719-720
Re: Bernhardt M, Hommerding O, Kreft T, Weinhold L, Schmid M, Kristiansen G, Prospective selective embedding of radical prostatectomy specimens is not inferior to full embedding regarding established and new prognostic parameters
Egevad L; Delahunt B; Samaratunga H
Review: PATHOLOGY INTERNATIONAL. 2025;75(5):213-220
The Role of Artificial Intelligence in the Evaluation of Prostate Pathology
Egevad L; Camilloni A; Delahunt B; Samaratunga H; Eklund M; Kartasalo K
Letter: PATHOLOGY. 2024;56(7):1059-1061
Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigen
Samaratunga H; Delahunt B; Olsson M; Aly M; Egevad L; Yaxley J
Editorial comment: PATHOLOGY. 2024;56(3):413-415
Florid basal cell hyperplasia mimics high PI-RADS score prostate cancer on mpMRI
Samaratunga H; Hussey D; Le Fevre IK; Egevad L; Sarikwal A; Carim H; Delahunt B
Letter: PATHOLOGY. 2024;56(1):141-142
Is grading of the index (dominant) nodule in prostate cancer of greater prognostic significance than global grading?
Samaratunga H; Egevad L; Delahunt B
Letter: PATHOLOGY. 2023;55(6):903-904
Not all tumour necrosis is granular necrosis
Samaratunga H; Egevad L; Delahunt B
Editorial comment: JOURNAL OF CLINICAL PATHOLOGY. 2023;76(5):291-292
Tumour grading: communication is the key
Varma M; Delahunt B; Cheng L; Chetty R; Comperat E; Deshpande V; Egevad L; van der Kwast TH; Lopez-Beltran A; McCluggage WG
Letter: PATHOLOGY. 2023;55(3):419-422
Late recurrence of renal solitary fibrous tumour in the contralateral kidney
Samaratunga H; Gianduzzo T; Perry-Keene J; Egevad L; Delahunt B
Editorial comment: BJU INTERNATIONAL. 2022;130(6):741-743
Low-grade prostate cancer should still be labelled cancer Comment
Iczkowski KA; Molina M; Egevad L; Bostwick DG; van Leenders GJLH; La Rosa FG; van der Kwast T; Berney DM; Evans AJ; Wheeler TM; Leite KRM; Samaratunga H; Srigley J; Varma M; Tsuzuki T; Lucia MS; Crawford ED; Harris RG; Stricker P; Lawrentschuk N; Woo HH; Fleshner NE; Shore ND; Yaxley J; Bratt O; Wiklund P; Roberts M; Cheng L; Delahunt B
Letter: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2022;46(9):1315-1317
In Reply: Intraductal Carcinoma of the Prostate and Nuclear Size
Samaratunga H; Delahunt B; Yaxley JW; Johannsen S; Egevad L
Letter: EUROPEAN UROLOGY. 2022;82(1):e15-e16
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019
Samaratunga H; Delahunt B; Egevad L
Editorial comment: PATHOLOGY. 2021;53(5):565-567
The emerging role of artificial intelligence in the reporting of prostate pathology
Egevad L; Delahunt B; Samaratunga H; Tsuzuki T; Yamamoto Y; Yaxley J; Ruusuvuori P; Kartasalo K; Eklund M
Review: EUROPEAN UROLOGY FOCUS. 2021;7(4):687-691
Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer in Biopsies-Current Status and Next Steps
Kartasalo K; Bulten W; Delahunt B; Chen P-HC; Pinckaers H; Olsson H; Ji X; Mulliqi N; Samaratunga H; Tsuzuki T; Lindberg J; Rantalainen M; Wahlby C; Litjens G; Ruusuvuori P; Egevad L; Eklund M
Letter: EUROPEAN UROLOGY. 2021;79(5):e141-e142
Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31 Should Chromophobe Renal Cell Carcinoma Be Graded?
Delahunt B; Samaratunga H; Egevad L
Editorial comment: BJU INTERNATIONAL. 2021;127(2):165-168
Prostate cancer grading, time to go back to the future
Egevad L; Delahunt B; Bostwick DG; Cheng L; Evans AJ; Gianduzzo T; Graefen M; Hugosson J; Kench JG; Leite KRM; Oxley J; Sauter G; Srigley JR; Stattin P; Tsuzuki T; Yaxley J; Samaratunga H
Editorial comment: PATHOLOGY. 2021;53(1):1-2
Recent advances in urological pathology
Egevad L; Samaratunga H; Eble JN
Review: PATHOLOGY. 2021;53(1):12-25
Prostatic stromal proliferations: a review
Bostwick DG; Egevad L
Letter: HISTOPATHOLOGY. 2021;78(2):342-344
Intraductal carcinoma of the prostate is not a diagnostic entity
Delahunt B; Egevad L; Samaratunga H; Srigley JR; Cheng L; Clouston D; Furusato B; Kench J; Leite KRM; MacLennan GT; Moch H; Pan C-C; Ro J; Tsuzuki T; van der Kwast T; Wheeler T; Yaxley JW
Editorial comment: HISTOPATHOLOGY. 2020;76(6):790-792
The utility of artificial intelligence in the assessment of prostate pathology
Egevad L; Strom P; Kartasalo K; Olsson H; Samaratunga H; Delahunt B; Eklund M
Review: PATHOLOGY. 2020;52(2):192-196
Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded
Samaratunga H; Delahunt B; Egevad L; Srigley JR; Billis A; Bostwick DG; Camparo P; Cheng L; Clouston D; Denham J; Furusato B; Hartmann A; Jufe L; Kench J; Kenwright DN; Kristiansen G; Leite KRM; MacLennan GT; Merrimen J; Moch H; Oxley J; Pan C-C; Paner G; Ro J; Sesterhenn IAM; Shanks J; Thunders M; Tsuzuki T; Wheeler T; Yaxley JW; Varma M
Review: VIRCHOWS ARCHIV. 2019;475(3):263-277
Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting
Kench JG; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Egevad L
Review: PATHOLOGY. 2019;51(5):463-473
Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation
Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan C-C; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
Review: VIRCHOWS ARCHIV. 2019;474(5):525-534
Intraductal carcinoma of the prostate: a critical re-appraisal
Varma M; Delahunt B; Egevad L; Samaratunga H; Kristiansen G
Review: PATHOLOGY INTERNATIONAL. 2019;69(2):55-66
Evolution, controversies and the future of prostate cancer grading
Egevad L; Delahunt B; Yaxley J; Samaratunga H
Review: HISTOPATHOLOGY. 2019;74(1):4-17
Grading of renal cell carcinoma
Delahunt B; Eble JN; Egevad L; Samaratunga H
Editorial comment: INTERNATIONAL BRAZ J UROL. 2018;44(6):1057-1062
The current status of renal cell carcinoma and prostate carcinoma grading
Delahunt B; Egevad L; Yaxley J; Samaratunga H
Letter: WORLD JOURNAL OF UROLOGY. 2018;36(8):1335-1336
Fuhrman grading is inappropriate for papillary renal cell carcinoma
Delahunt B; Egevad L; Srigley JR; Samaratunga H
Letter: HISTOPATHOLOGY. 2018;73(2):361-362
Re: Comment on Egevad et al., "Utility of Pathology Imagebase for standardisation of prostate cancer grading'
Egevad L; Samaratunga H; Delahunt B
Review: PATHOLOGY. 2018;50(1):60-73
Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations
Egevad L; Delahunt B; Kristiansen G; Samaratunga H; Varma M
Editorial comment: PATHOLOGY. 2017;49(7):673-674
The decline of medical publishing: the rise of the pseudo-journal
Delahunt B; Samaratunga H; Egevad L
Corrigendum: EUROPEAN UROLOGY. 2017;72(5):E147
Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response (vol 71, pg 776, 2017)
Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikstrom P
Editorial comment: HISTOPATHOLOGY. 2017;71(1):5-11
UICC drops the ball in the 8th edition TNM staging of urological cancers
Delahunt B; Egevad L; Samaratunga H; Varma M; Verrill C; Cheville J; Kristiansen G; Corbishley C; Berney DM
Letter: HISTOPATHOLOGY. 2017;70(6):1013-1014
Reply: 'A plea for greater standardization in intraductal carcinoma of the prostate - greater standardization requires greater evidence': let's use the available evidence
Varma M; Egevad L; Delahunt B; Kristiansen G
Editorial comment: INTERNATIONAL JOURNAL OF UROLOGY. 2017;24(4):286-287
Editorial Comment to Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam
Egevad L; Samaratunga H; Delahunt B
Corrigendum: EBIOMEDICINE. 2017;17:238
Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study (vol 2, pg 1133, 2015)
Ross-Adams H; Lamb AD; Dunning MJ; Halim S; Lindberg J; Massie CM; Egevad LA; Russell R; Ramos-Montoya A; Vowler SL; Sharma NL; Kay J; Whitaker H; Clarkh J; Hurst R; Gnanapragasam VJ; Shah NC; Warren AY; Cooper CS; Lynch AG; Stark R; Mills IG; Gronberg H; Neal DE
Review: HISTOPATHOLOGY. 2017;70(4):513-521
The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel
Idrees MT; Ulbright TM; Oliva E; Young RH; Montironi R; Egevad L; Berney D; Srigley JR; Epstein JI; Tickoo SK
Letter: HISTOPATHOLOGY. 2017;70(3):504-507
Reporting intraductal carcinoma of the prostate: a plea for greater standardization
Varma M; Egevad L; Delahunt B; Kristiansen G
Letter: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2017;141(2):182-183
Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System
Delahunt B; Grignon DJ; Samaratunga H; Srigley JR; Leite KRM; Kristiansen G; Evans AJ; Kench JG; Egevad L
Review: HISTOPATHOLOGY. 2017;70(3):335-346
The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel
Williamson SR; Delahunt B; Magi-Galluzzi C; Algaba F; Egevad L; Ulbright TM; Tickoo SK; Srigley JR; Epstein JI; Berney DM; Amin MB; Comperat E; Humphrey PA; Idrees MT; Lopez-Beltran A; Montironi R; Oliva E; Perry-Keene J; Verrill C; Yilmaz A; Young RH; Zhou M
Letter: EUROPEAN UROLOGY. 2017;71(2):e52-e53
Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1
Egevad L; Samaratunga H; Srigley JR; Delahunt B
Editorial comment: JOURNAL OF UROLOGY. 2017;197(1):81-82
Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance
Egevad L
Letter: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2016;96(5):1126-1127
Editorial Statement on Gleason Scoring for Prostate Cancer
Egevad L; Samaratunga H; Srigley JR; Delahunt B
Letter: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2016;34(11):479-480
New Gleason grading system: Statement from the editors of 6 journals
Egevad L; Samaratunga H; Srigley JR; Delahunt B
Letter: UROLOGY. 2016;96:179-180
Re: Samaratunga et al: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade Reply
Egevad L; Samaratunga H; Srigley JR; Delahunt B
Letter: JOURNAL OF UROLOGY. 2016;196(4):1321-1323
Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade
Egevad L; Samaratunga H; Srigley JR; Delahunt B
Review: SCANDINAVIAN JOURNAL OF UROLOGY. 2016;50(5):325-329
From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer
Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
Review: CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL. 2016;10(9-10):339-341
One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason grading
Srigley JR; Delahunt B; Egevad L; Samaratunga H; Yaxley J; Evans AJ
Letter: BJU INTERNATIONAL. 2016;118(3):E1-E2
Consensus guidelines for reporting prostate cancer Gleason Grade
Egevad L; Samaratunga H; Srigley JR; Delahunt B
Review: PATHOLOGY. 2016;48(5):398-405
Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features
Seipel AH; Delahunt B; Samaratunga H; Egevad L
Letter: HISTOPATHOLOGY. 2016;69(2):341-342
Reply: Gleason and Fuhrman no longer make the grade
Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
Letter: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2016;40(6):858-861
International Society of Urological Pathology (ISUP) Grading of Prostate Cancer
Egevad L; Delahunt B; Evans AJ; Grignon DJ; Kench JG; Kristiansen G; Leite KR; Samaratunga H; Srigley JR
Editorial comment: APMIS. 2016;124(6):433-435
International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading
Egevad L; Delahunt B; Srigley JR; Samaratunga H
Editorial comment: JOURNAL OF UROLOGY. 2016;195(5):1420
Untitled
Egevad L
Editorial comment: EUROPEAN UROLOGY. 2016;69(4):599-600
Utility of Reporting the Percentage of High-grade Prostate Cancer
Egevad L; Delahunt B; Samaratunga H; Srigley JR
Review: HISTOPATHOLOGY. 2016;68(4):475-481
Gleason and Fuhrman no longer make the grade
Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
Review: PATHOLOGE. 2015;36(3):310-316
Vancouver classification of renal tumors. Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)
Kristiansen G; Delahunt B; Srigley JR; Lueders C; Lunkenheimer J-M; Gevensleben H; Thiesler T; Montironi R; Egevad L
Corrigendum: MOLECULAR CANCER. 2015;14:88
OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo (vol 14, 8, 2015)
Iglesias-Gato D; Chuan Y-C; Jiang N; Svensson C; Bao J; Shang Z; Paul I; Egevad L; Kessler BM; Wikstrom P; Niu Y; Flores-Morales A
Editorial comment: PATHOLOGY. 2015;47(1):1-3
Active surveillance for prostate cancer: the role of the pathologist
Delahunt B; Hammond E; Egevad L; Samaratunga H; Srigley JR; Humphrey PA; Rubin M; Epstein JI; Lin DW; Gore JL; Nacey JN; Klotz L; Sandler H; Zietman AL; Holden S; Montironi R; Evans AJ; McKenney JK; Berney D; Wheeler TM; Chinnaiyan AM; True L; Knudsen B; Amin MB
Editorial comment: PATHOLOGY. 2014;46(7):579-580
Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submission
Srigley JR; Delahunt B; Egevad L; Samaratunga H; Evans AJ
Editorial comment: EUROPEAN UROLOGY. 2014;66(5):795-798
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia
Delahunt B; Srigley JR; Egevad L; Montironi R
Review: VIRCHOWS ARCHIV. 2014;464(3):359-365
Biomarkers in renal cancer
Moch H; Srigley J; Delahunt B; Montironi R; Egevad L; Tan PH
Editorial comment: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2013;37(10):1463-1468
International Society of Urological Pathology (ISUP) Consensus Conference on Renal Neoplasia Rationale and Organization
Delahunt B; Egevad L; Montironi R; Srigley JR
Review: EUROPEAN UROLOGY. 2013;63(5):892-901
Contemporary Grading for Prostate Cancer: Implications for Patient Care
Brimo F; Montironi R; Egevad L; Erbersdobler A; Lin DW; Nelson JB; Rubin MA; van der Kwast T; Amin M; Epstein JI
Editorial comment: ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY. 2012;34(6):293-295
Recent Advances in Urological Pathology
Montironi R; Srigley JR; Egevad L; Delahunt B
Editorial comment: PATHOLOGY. 2012;44(5):389-390
Urological pathology comes of age
Delahunt B; Srigley JR; Montironi R; Egevad L
Review: EUROPEAN UROLOGY. 2012;62(1):20-39
A Contemporary Update on Pathology Reporting for Prostate Cancer: Biopsy and Radical Prostatectomy Specimens
Fine SW; Amin MB; Berney DM; Bjartell A; Egevad L; Epstein JI; Humphrey PA; Magi-Galluzzi C; Montironi R; Stief C
Review: APMIS. 2012;120(4):298-304
Utility of whole slide imaging and virtual microscopy in prostate pathology
Camparo P; Egevad L; Algaba F; Berney DM; Boccon-Gibod L; Comperat E; Evans AJ; Grobholz R; Kristiansen G; Langner C; Lopez-Beltran A; Montironi R; Oliveira P; Vainer B; Varma M
Review: LAKARTIDNINGEN. 2012;109(8):403-406
[The pathologist's role: to diagnose prostatic cancer and determine prognosis].
Egevad L
Review: HISTOPATHOLOGY. 2012;60(1):118-124
Handling of radical prostatectomy specimens
Egevad L
Letter: HISTOPATHOLOGY. 2011;59(5):1011-1012
Handling of radical prostatectomy specimens: total or partial embedding?
Egevad L
Review: PATHOLOGY. 2011;43(5):410-419
Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens
Kench JG; Clouston DR; Delprado W; Eade T; Ellis D; Horvath LG; Samaratunga H; Stahl J; Stapleton AMF; Egevad L; Srigley JR; Delahunt B
Review: ADVANCES IN ANATOMIC PATHOLOGY. 2011;18(4):301-305
International Society of Urological Pathology Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens
Egevad L; Srigley JR; Delahunt B
Review: ACTA ONCOLOGICA. 2011;50:49-52
Pathology in prostate research: Optimizing the pathological data
Berney DM; Montironi R; Egevad L
Review: ACTA ONCOLOGICA. 2011;50:76-84
Tumour markers in prostate cancer II: Diagnostic and prognostic cellular biomarkers
Bjartell A; Montironi R; Berney DM; Egevad L
Review: ACTA ONCOLOGICA. 2011;50:56-60
Role of histopathology and molecular markers in the active surveillance of prostate cancer
Montironi R; Egevad L; Bjartell A; Berney DM
Review: ACTA ONCOLOGICA. 2011;50:53-55
Pathology in prostate research: Optimizing tissue quality
Berney DM; Montironi R; Egevad L
Meeting abstract: EUROPEAN UROLOGY OPEN SCIENCE. 2011;10(2):324-325
NATION-WIDE POPULATION-BASED STUDY ON 15-YEAR MORTALITY IN PROSTATE CANCER ACCORDING TO RISK CATEGORIES IN THE NATIONAL PROSTATE CANCER REGISTER (NPCR) OF SWEDEN
Stattin P; Sandin F; Ahlgren G; Bratt O; Damber JE; Hugosson J; Pettersson B; Robinson D; Tornblom M; Karlsson S; Andren O; Bill-Axelson A; Widmark A; Egevad L; Ehrnstrom R; Adolfsson J; Lambe M; Johansson JE
Review: MODERN PATHOLOGY. 2011;24(1):1-5
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens: rationale and organization
Egevad L; Srigley JR; Delahunt B
Review: MODERN PATHOLOGY. 2011;24(1):6-15
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling
Samaratunga H; Montironi R; True L; Epstein JI; Griffiths DF; Humphrey PA; van der Kwast T; Wheeler TM; Srigley JR; Delahunt B; Egevad L
Review: MODERN PATHOLOGY. 2011;24(1):39-47
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes
Berney DM; Wheeler TM; Grignon DJ; Epstein JI; Griffiths DF; Humphrey PA; van der Kwast T; Montironi R; Delahunt B; Egevad L; Srigley JR
Review: MODERN PATHOLOGY. 2011;24(1):16-25
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume
van der Kwast TH; Amin MB; Billis A; Epstein JI; Griffiths D; Humphrey PA; Montironi R; Wheeler TM; Srigley JR; Egevad L; Delahunt B
Review: MODERN PATHOLOGY. 2011;24(1):26-38
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease
Magi-Galluzzi C; Evans AJ; Delahunt B; Epstein JI; Griffiths DF; van der Kwast TH; Montironi R; Wheeler TM; Srigley JR; Egevad LL; Humphrey PA
Review: MODERN PATHOLOGY. 2011;24(1):48-57
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins
Tan PH; Cheng L; Srigley JR; Griffiths D; Humphrey PA; van der Kwast TH; Montironi R; Wheeler TM; Delahunt B; Egevad L; Epstein JI
Review: INTERNATIONAL JOURNAL OF UROLOGY. 2010;17(1):6-19
Genetic profiles in renal tumors
Lopez-Beltran A; Montironi R; Egevad L; Caballero-Vargas MT; Scarpelli M; Kirkali Z; Cheng L
Review: HISTOLOGY AND HISTOPATHOLOGY. 2009;24(5):661-666
Modified gleason grading. An updated review
Helpap B; Egevad L
Other: EUROPEAN UROLOGY. 2009;55(5):1247-1249
Donald F. Gleason, 1920-2008 Obituary
Egevad L; Montorsi F; Montironi R
Review: SEMINARS IN DIAGNOSTIC PATHOLOGY. 2008;25(4):232-244
Targeted therapies and biological modifiers in urologic tumors: pathobiology and clinical implications
Lopez-Beltran A; Kirkali Z; Cheng L; Egevad L; Regueiro JC; Blanca A; Montironi R
Editorial comment: JOURNAL OF UROLOGY. 2008;180(2):552
The impact of the 2005 International Society of Urological Pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies - Comment
Egevad L
Review: TUMOR BIOLOGY. 2008;29(5):311-322
Current Status of Prognostic Immunohistochemical Markers for Urothelial Bladder Cancer
Rosenblatt R; Jonmarker S; Lewensohn R; Egevad L; Sherif A; Kalkner KM; Nilsson S; Valdman A; Ullen A
Review: VIRCHOWS ARCHIV. 2007;451(6):987-997
Pseudoneoplastic lesions of the testis and paratesticular structures
Algaba F; Mikuz G; Boccon-Gibod L; Trias I; Arce Y; Montironi R; Egevad L; Scarpelli M; Lopez-Beltran A
Review: PROTEOMICS CLINICAL APPLICATIONS. 2007;1(9):1058-1065
Proteomics in clinical prostate research
Hellstrom M; Jonmarker S; Lehtio J; Auer G; Egevad L
Review: UROLOGE. 2007;46(1):59-62
The value of the modified Gleason grading system of prostate adenocarcinoma in routine urological diagnostics
Helpap B; Egevad L
Review: ADVANCES IN ANATOMIC PATHOLOGY. 2006;13(1):57-59
Update on the Gleason grading system for prostate cancer - Results of an international consensus conference of urologic pathologists
Epstein JI; Allsbrook WC; Amin MB; Egevad LL
Published conference paper: PROTEOMICS. 2005;5(10):2570-2576
Differential protein expression in anatomical zones of the prostate
Lexander H; Franzén B; Hirschberg D; Becker S; Hellström M; Bergman T; Jörnvall H; Auer G; Egevad L
Published conference paper: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, SUPPLEMENT. 2005;39(216):34-63
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens
Epstein JI; Amin M; Boccon-Gibod L; Egevad L; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Srigley JR; Wheeler TM; Montironi R
Published conference paper: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, SUPPLEMENT. 2005;39(216):20-33
Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens
Amin M; Boccon-Gibod L; Egevad L; Epstein JI; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Srigley JR; Wheeler TM; Montironi R
Published conference paper: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, SUPPLEMENT. 2005;39(216):8-19
Prognostic and predictive factors in prostate cancer: Historical perspectives and recent international consensus initiatives
Srigley JR; Amin M; Boccon-Gibod L; Egevad L; Epstein JI; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Wheeler TM; Montironi R
Review: CANCER SURVEYS. 1998;32:149-179
Precancer of the prostate
Busch PC; Egevad L; Haggman M
Visa fler

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI